Sleep apnoea

G6_SLEEPAPNO

sleep apnea: A disorder characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G47.3 Hospital discharge: ICD-9 — 3472 Cause of death: ICD-10 — G47.3 Cause of death: ICD-9 — 3472 2 out of 7 registries used, show all original rules.	64250
4. Check minimum number of events None	64250
5. Include endpoints None	64250
6. Filter based on genotype QC (FinnGen only)	62442

Control definitions (FinnGen only)

Control exclude: G6_NARCOCATA, G6_SLEEPDISOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G47
Name in latin: Apnoea intrasomnalis

NAME	G6_SLEEPAPNO
CONTROL_EXCLUDE	G6_NARCOCATA\|G6_SLEEPDISOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G473
HD_ICD_9	3472
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G473
COD_ICD_9	3472
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleep apnoea based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	299915	99073	199632
Only index persons	288611	96978	191633
Unadjusted period prevalence (%)
Whole population	4.66	2.84	5.58
Only index persons	6.06	3.57	7.32
Median age at first event (years)
Whole population	54.62	57.21	53.35
Only index persons	54.55	57.21	53.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	62442	26246	36196
Unadjusted period prevalence (%)	13.53	9.31	16.58
Median age at first event (years)	56.84	57.42	56.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
55450: Matched controls
358832

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

322.6

5624

20965

OAB72, ,

SPAT

5.4

320.6

753

906

R29

ICPC

Respiratory symptom/complaint other

2.1

320.2

3425

10758

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

320.1

9183

39273

R05

ICPC

Cough

1.5

319.3

11568

52249

G04CA02

ATC

tamsulosin; oral

1.6

319.2

10609

46989

M01AC06

ATC

meloxicam; systemic, rectal

1.5

319.0

17902

88501

XF402

NOMESCO Finland

ECG with work load test

1.9

318.8

5102

18508

C09CA03

ATC

valsartan; oral

1.9

318.5

4524

15772

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

317.2

5035

18215

E66.0

ICD-10 Finland

Obesity due to excess calories

5.7

316.0

703

800

J01MA12

ATC

levofloxacin; systemic

1.6

313.8

8914

38008

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.1

313.0

1544

3314

WX780, ,

SPAT

17.8

312.6

340

124

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

312.5

5902

22528

207

Kela drug reimbursment

Chronic arrhythmias

1.7

312.2

6772

26899

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

312.2

2412

6582

N06AA09

ATC

amitriptyline; systemic

1.9

312.0

4670

16566

R4110, ,

SPAT

2.0

311.9

4249

14597

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

311.3

4428

15440

B01AB05

ATC

enoxaparin; parenteral

1.5

311.3

15251

73341

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.0

310.8

1638

3657

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

310.3

12212

56114

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

309.8

6185

23993

SFA30

NOMESCO Finland

Three-surface restoration

1.5

307.7

22294

110033

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

30955

162939

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

307.7

2716

6742

J96.1

ICD-10 Finland

Chronic respiratory failure

4.1

307.7

1191

1911

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.8

307.7

3352

7940

AA40B, ,

NOMESCO Finland

124.3

307.7

589

SPAT1153

SPAT

Removal of sutures

1.5

307.7

15497

72780

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

307.7

27575

139320

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

307.7

11420

45398

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

307.7

24723

127270

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

307.7

4745

14304

N04BC05

ATC

pramipexole; oral

2.3

307.7

4065

11708

P06

ICPC

Sleep disturbance

4.9

307.7

10749

16904

R53

ICD-10 Finland

Malaise and fatigue

1.8

307.7

12594

49456

WX722

NOMESCO Finland

PEEP

26.7

307.7

6539

1785

SPAT1097

SPAT

Recording of ECG

1.7

307.7

7010

27567

N06AX26

ATC

vortioxetine; oral

2.3

307.7

3977

11444

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

307.7

14342

54248

OAB72

NOMESCO Finland

Weight control and weight loss guidance

9.0

307.7

673

490

L08

ICPC

Shoulder symptom/complaint

1.6

307.7

10895

47641

R06AE07

ATC

cetirizine; oral

1.5

307.7

22226

112947

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

19.8

307.7

666

220

C09CA01

ATC

losartan; oral

1.8

307.7

13369

54433

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

307.7

13342

48540

P76

ICPC

Depressive disorder

2.2

307.7

3316

10026

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

307.7

5593

19849

SPAT1058

SPAT

PEF monitoring instruction

2.1

307.7

4084

13239

WX723, ,

SPAT

13.6

307.7

542

260

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

307.7

10909

44086

J01DA01

ATC

[U] cefalexin

1.4

307.7

31788

172718

N06AB06

ATC

sertraline; oral

1.9

307.7

5770

20488

J01AA02

ATC

doxycycline; systemic

1.8

307.7

42504

230547

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

307.7

10550

39771

N06AX12

ATC

bupropion; oral

2.9

307.7

4598

10822

A10BJ02

ATC

liraglutide; parenteral

6.2

307.7

2498

2698

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.4

307.7

9601

28460

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

19.4

307.7

19748

9960

162

Kela drug reimbursment

liraglutide

6.6

307.7

794

792

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

307.7

8687

36114

R99

ICPC

Respiratory disease other

6.4

307.7

1470

1514

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

307.7

11040

43443

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

22130

101645

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

6.6

307.7

1357

1361

UJF32

NOMESCO Finland

Coloscopy

1.6

307.7

13187

58192

M01AH05

ATC

etoricoxib; oral

1.7

307.7

34303

175154

L28

ICPC

Limited function/disability (L)

1.7

307.7

8169

32738

N03AX12

ATC

[U] gabapentin; oral

1.9

307.7

8754

32948

R06.5

ICD-10 Finland

Mouth breathing

10.2

307.7

11389

8896

E66.01

ICD-10 Finland

Obesity due to excess calories

6.6

307.7

9493

10907

R01AD58

ATC

fluticasone, combinations; nasal

1.8

307.7

13702

54222

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

307.7

3729

11228

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

25522

111838

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

307.7

22404

111715

A10BK01

ATC

dapagliflozin; oral

2.6

307.7

4126

10919

H02AB06

ATC

prednisolone; systemic

1.8

307.7

26259

121608

C03DA01

ATC

spironolactone; oral

2.0

307.7

5829

20072

D82

ICPC

Teeth/gum disease

1.5

307.7

18273

89948

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

307.7

2267

5867

N06AX16

ATC

venlafaxine; oral

2.3

307.7

8851

27027

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.5

307.7

1417

2100

R02

ICPC

Shortness of breath/dyspnoea

2.1

307.7

7105

23177

J01FA10

ATC

azithromycin; systemic

1.5

307.7

29471

156666

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

307.7

13789

64443

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

307.7

7205

27055

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

307.7

11990

53992

205

Kela drug reimbursment

Chronic hypertension

1.9

307.7

13186

51631

M04AA01

ATC

allopurinol; systemic

2.1

307.7

6468

21687

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

5.6

307.7

757

889

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.8

307.7

3196

7761

R5140

NOMESCO Finland

Monitoring the use of the aid

52.5

307.7

21121

4157

SPAT1377

SPAT

Polysomnography

12.4

307.7

4028

2261

C09DA06

ATC

candesartan and diuretics; oral

2.1

307.7

3825

12457

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

307.7

6393

22763

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

14.5

307.7

1010

457

P03

ICPC

Feeling depressed

2.0

307.7

4781

15915

XG466

NOMESCO Finland

Sleep oxymetry

21.6

307.7

4116

1329

R01AD09

ATC

mometasone; nasal

2.0

307.7

27115

114427

M03BX02

ATC

tizanidine; oral

1.7

307.7

34668

177624

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

43136

247358

XG410

NOMESCO Finland

Flow-volume spirometry

2.7

307.7

2078

5095

160

Kela drug reimbursment

exenatide

5.8

307.7

1421

1625

D07AC01

ATC

betamethasone; topical

1.5

307.7

17964

88403

SPAT1094

SPAT

Continuous Positive Airway Pressure

115.5

307.7

1545

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

43.2

307.7

522

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.3

307.7

2337

4652

A10BK03

ATC

empagliflozin; oral

2.8

307.7

6069

15243

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

22614

102283

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

307.7

11481

49614

R03BA08

ATC

ciclesonide; inhalant

2.1

307.7

4777

15265

C07AB07

ATC

bisoprolol; oral

1.9

307.7

25993

115590

E66.9

ICD-10 Finland

Obesity, unspecified

6.3

307.7

3095

3352

G47.3

ICD-10 Finland

Sleep apnoea

4434.4

307.7

54793

6624

A10BJ06

ATC

semaglutide; parenteral

4.9

307.7

4118

5740

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

16743

76257

T83

ICPC

Overweight

3.7

307.7

1291

2318

ENC30

NOMESCO Finland

Plastic operation of pharynx

9.3

307.7

1132

806

M54.5

ICD-10 Finland

Low back pain

1.7

307.7

19731

86679

R04

ICPC

Breathing problem other

4.3

307.7

2729

4241

E66

ICD-10 Finland

Obesity

5.0

307.7

4597

6331

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

23887

121398

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.4

307.7

5671

16398

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

24663

115510

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

307.7

5593

16673

J01FA06

ATC

roxithromycin; oral

1.5

307.7

19944

99274

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

307.7

9754

38245

C10AA01

ATC

simvastatin; oral

1.6

307.7

20222

94467

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

307.7

1710

R01AD08

ATC

fluticasone; nasal

1.8

307.7

16034

66159

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.4

307.7

15627

50064

R03BA02

ATC

budesonide; inhalant

1.7

307.7

9043

36837

E66.8

ICD-10 Finland

Other obesity

6.8

307.7

5847

6094

4471

FHL

Pharyngoplasty

26.1

307.7

400

100

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

307.7

3253

8659

M10.9

ICD-10 Finland

Gout, unspecified

2.2

307.7

3380

10180

GX2D5

NOMESCO Finland

Sleep oximetry

14.1

307.7

634

294

A46

ICD-10 Finland

Erysipelas

1.9

307.7

7442

27531

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.3

307.7

2513

3929

N02AX02

ATC

tramadol; systemic, rectal

1.8

307.7

24213

108109

R03BA05

ATC

fluticasone; inhalant

1.8

307.7

9391

37381

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

307.7

11782

52093

SPAT1312

SPAT

General health counselling

1.5

307.7

15154

71132

M79.7

ICD-10 Finland

Fibromyalgia

2.9

307.7

1992

4587

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

29145

152375

J34.2

ICD-10 Finland

Deviated nasal septum

3.3

307.7

3669

7457

C02AC05

ATC

moxonidine; oral

2.6

307.7

2333

5990

C10AA05

ATC

atorvastatin; oral

1.8

307.7

22188

97816

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

307.7

19719

95905

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

307.7

9268

38003

R05

ICD-10 Finland

Cough

1.6

307.7

10631

45516

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

307.7

18364

89917

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

307.7

17971

88083

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

307.7

6846

26101

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

307.7

34753

187684

RK320, ,

NOMESCO Finland

8.2

307.7

597

477

3051, ,

Kela drug reimbursment

8.1

307.7

867

704

XA420

NOMESCO Finland

Extensive sleep examination

36.7

307.7

1351

244

C10AA07

ATC

rosuvastatin; oral

1.7

307.7

17043

73380

C08CA13

ATC

lercanidipine; oral

2.0

307.7

7378

25700

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

307.7

13360

57414

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

307.7

6136

21959

R03BB04

ATC

tiotropium bromide; inhalant

2.2

307.7

5440

16555

N06AB10

ATC

escitalopram; oral

1.9

307.7

11286

42820

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

307.7

3499

10437

SPAT1051

SPAT

Guidance regarding sleep disorders

7.8

307.7

1275

1076

N06AX11

ATC

mirtazapine; oral

1.7

307.7

18351

80041

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

307.7

12607

46685

G04BD12

ATC

mirabegron; oral

1.9

307.7

5606

20391

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

307.7

18323

88424

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

15171

68887

C09DA01

ATC

losartan and diuretics; oral

2.0

307.7

5532

18635

WX780

NOMESCO Finland

Remote monitoring CPAP

3823.9

307.7

8505

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

14800

64120

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

307.7

4492

13718

A02BC03

ATC

lansoprazole; oral

1.6

307.7

14353

65481

C10AX09

ATC

ezetimibe; oral

1.8

307.7

7884

30269

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

307.7

15359

61755

N06AB04

ATC

citalopram; systemic

1.9

307.7

11547

43622

SBB10

NOMESCO Finland

Dental impressions

2.8

307.7

3600

8663

C09CA06

ATC

candesartan; oral

1.7

307.7

12629

52609

SPAT1263

SPAT

Sampling

1.7

307.7

21855

101359

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

307.7

3078

6245

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

307.7

15344

61455

N03AX16

ATC

[U] pregabalin

1.8

307.7

12825

50548

L15

ICPC

Knee symptom/complaint

1.8

307.7

12370

50578

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

307.7

2567

6184

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

307.7

11390

36415

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.8

307.7

4545

6556

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

20.3

307.7

340

109

SPAT1262

SPAT

Handing over of treatment supplies

2.4

307.7

10631

32812

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

7.6

307.7

593

508

T90

ICPC

Diabetes non-insulin dependent

2.5

307.7

15128

47045

A10AE04

ATC

insulin glargine; parenteral

1.9

307.7

4754

16650

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.8

307.7

4895

7058

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

307.7

38472

208922

SPAT1310

SPAT

Counselling related to known health issue

1.7

307.7

16233

71253

R60.0

ICD-10 Finland

Localized oedema

2.0

307.7

6201

21739

A10BA02

ATC

metformin; oral

2.5

307.7

17788

56912

C03AA03

ATC

hydrochlorothiazide; oral

2.0

307.7

4239

14278

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

307.7

3220

8140

A02BC01

ATC

omeprazole; systemic

1.5

307.7

13076

60216

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

307.7

2365

5614

WX723

NOMESCO Finland

CPAP therapy

995.4

307.7

7913

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

307.7

11586

51301

I10

ICD-10 Finland

Essential (primary) hypertension

2.4

307.7

35385

150713

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

37840

191111

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

11611

45453

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

307.7

16252

54382

G47.9

ICD-10 Finland

Sleep disorder, unspecified

6.6

307.7

2003

2029

DHB50

NOMESCO Finland

Turbinoplasty

4.4

307.7

1853

2810

A10BH01

ATC

sitagliptin; oral

2.3

307.7

5111

15408

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

17.9

307.7

1090

402

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.5

307.7

14626

45575

OAB50, ,

SPAT

2.6

307.7

3097

8125

J01DB01

ATC

cefalexin; oral

1.9

307.7

45623

252826

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

24238

124383

C08CA01

ATC

amlodipine; oral

1.9

307.7

20582

85508

N02BE01

ATC

paracetamol; systemic, rectal

2.2

307.7

49072

278066

N06AB03

ATC

fluoxetine; oral

2.0

307.7

6472

22771

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

23133

116491

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

307.7

13908

63509

E66.00

ICD-10 Finland

Metabolic syndrome

5.5

307.7

5106

6472

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

16484

54252

C03CA01

ATC

furosemide; systemic

1.9

307.7

14658

56963

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

38141

206278

N06AX21

ATC

duloxetine; oral

2.5

307.7

7387

21104

R01AD12

ATC

fluticasone furoate; nasal

1.9

307.7

18147

72768

R96

ICPC

Asthma

2.1

307.7

4947

16355

T82

ICPC

Obesity

6.5

307.7

3907

4145

N05AH04

ATC

quetiapine; oral

1.9

307.7

9311

35291

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

32505

143319

SFA10

NOMESCO Finland

One-surface restoration

1.5

307.7

28462

148249

M79.6

ICD-10 Finland

Pain in limb

1.7

307.7

22862

103632

L03

ICPC

Low back symptom/complaint

1.7

307.7

14425

61352

J45

ICD-10 Finland

Asthma

2.0

307.7

5538

18783

R03DC03

ATC

montelukast; oral

1.9

307.7

9087

33302

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

307.7

19674

93235

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

307.7

7223

28222

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

23616

107124

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

307.7

7268

25523

A10BX07

ATC

[U] liraglutide

6.5

307.7

902

913

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

307.7

29777

152200

ZXC60

NOMESCO Finland

Application of heat

5.8

307.7

1190

1349

J01FA09

ATC

clarithromycin; systemic

1.5

307.7

15755

74840

N05BA04

ATC

oxazepam; oral

1.6

307.7

12857

57180

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

307.7

4376

14959

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

307.7

7126

23055

J01FF01

ATC

clindamycin; systemic

1.6

307.7

13983

63187

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

307.7

13312

56208

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

307.7

7724

22959

EB1MA

NOMESCO Finland

Cephalometry with X-ray

8.5

307.7

1576

1226

XA421

NOMESCO Finland

Nocturnal polygraphy

29.3

307.7

610

136

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

307.7

7358

26344

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

307.7

7982

30400

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

35767

191213

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

307.7

20481

99791

RK323, ,

NOMESCO Finland

30.8

307.7

303

S18

ICPC

Laceration/cut

1.6

307.7

23569

114681

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

307.7

15178

65238

SFA20

NOMESCO Finland

Two-surface restoration

1.5

307.7

31169

163238

A10BJ05

ATC

dulaglutide; parenteral

5.0

307.7

1396

1853

Z3231

NOMESCO Finland

Registered nurse

1.5

306.0

13191

61764

C09AA02

ATC

enalapril; systemic

1.6

305.0

8738

37308

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.3

303.8

2593

7404

N05CF01

ATC

zopiclone; oral

1.5

303.5

15358

74249

M48.0

ICD-10 Finland

Spinal stenosis

1.8

302.5

5709

21774

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

300.7

15108

72909

H03AA01

ATC

levothyroxine sodium; systemic

1.5

299.7

11047

49986

R51.80

ICD-10 Finland

Headache

1.7

297.1

7373

30336

SPAT1240

SPAT

Therapeutic discussion

1.8

296.3

4937

18119

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

296.0

2588

7467

A10BX04

ATC

[U] exenatide

5.7

293.8

658

754

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

293.6

2482

7055

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

293.2

4984

18403

C01DA14

ATC

isosorbide mononitrate; oral

1.7

292.5

6182

24346

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

292.1

6357

25240

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

92.2

291.9

227

M02AA07

ATC

piroxicam; topical

1.4

291.3

17141

85135

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

291.3

10824

49019

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

290.0

17771

88908

R03BA01

ATC

beclometasone; inhalant

1.7

288.8

6799

27572

SPAT1260

SPAT

Consultation of another employee

1.6

288.2

8367

35787

N02BF01

ATC

gabapentin; oral

1.9

286.4

4043

14044

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

285.8

5038

18805

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

285.6

20213

103691

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

285.2

3339

10845

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.9

285.2

1539

3482

C09AA05

ATC

ramipril; oral

1.5

283.7

11258

51671

R42

ICD-10 Finland

Dizziness and giddiness

1.5

281.6

10583

47996

D01BA02

ATC

terbinafine; oral

1.5

281.2

12571

59123

G04CA01

ATC

alfuzosin; oral

1.7

279.7

5653

21964

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

278.8

4889

18211

AA1AD

NOMESCO Finland

CT of head and brain

1.5

278.6

12591

59327

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

278.4

14004

67395

E0000UV, ,

ATC

1.4

276.7

20143

103671

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

275.1

4011

14079

M79.1

ICD-10 Finland

Myalgia

1.6

271.5

6931

28672

ACC51

NOMESCO Finland

Release of median nerve

1.9

270.1

3782

13091

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.0

268.2

1394

3085

N03AX09

ATC

lamotrigine; oral

2.3

267.7

2413

7049

P01AB01

ATC

metronidazole; oral, rectal

1.4

266.3

19577

100735

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

266.1

9225

41038

M01AH01

ATC

celecoxib; oral

1.6

264.3

8522

37287

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

263.2

1772

4516

R06.2

ICD-10 Finland

Wheezing

2.3

262.9

2209

6256

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

262.6

5924

23705

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

261.6

6057

24407

R06AX27

ATC

desloratadine; oral

1.4

260.2

13781

66811

L16

ICPC

Ankle symptom/complaint

1.7

259.8

5300

20622

SPAT1301

SPAT

No procedures

1.4

259.4

14494

70965

C07AB02

ATC

metoprolol; systemic

1.6

259.3

8653

38138

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

258.6

11071

51474

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

258.6

5478

21540

R03AC03

ATC

terbutaline; inhalant

1.6

257.5

6663

27627

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

257.4

2806

8859

SDA03

NOMESCO Finland

Periodontal treatment

1.4

256.8

19746

102199

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

254.8

3647

12709

F32

ICD-10 Finland

Depressive episode

2.1

254.8

2670

8299

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

252.8

7135

30219

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

251.4

24250

130076

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

251.3

8319

36572

UKC02

NOMESCO Finland

Cystoscopy

1.6

250.6

7232

30791

XKD00

NOMESCO Finland

Uroflowmetry

1.6

250.4

6993

29535

F34.1

ICD-10 Finland

Dysthymia

2.5

250.1

1848

4929

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

249.5

34708

197139

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

248.9

13046

63029

R01AD01

ATC

beclometasone; nasal

1.6

248.2

7385

31666

M01AX17

ATC

nimesulide; oral

1.5

246.8

11056

51806

B01AF01

ATC

rivaroxaban; oral

1.7

246.0

5691

22900

J20

ICD-10 Finland

Acute bronchitis

1.7

246.0

4946

19147

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

7.8

245.6

421

352

G44.2

ICD-10 Finland

Tension-type headache

1.6

245.6

6448

26811

N05CF02

ATC

zolpidem; oral

1.5

245.5

8460

37509

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

245.5

18886

97549

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

245.0

13543

66040

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

243.9

9137

41249

A02BA02

ATC

ranitidine; systemic

1.5

243.3

8661

38668

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

243.1

6188

25524

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

242.8

4159

15351

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.0

242.3

617

803

J01MA02

ATC

ciprofloxacin; systemic

1.4

241.7

18605

96036

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.5

241.1

10199

47210

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

240.9

48140

290529

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

239.9

6514

27299

L13

ICPC

Hip symptom/complaint

1.5

239.1

8217

36388

A98

ICPC

Health maint/preventive medicine

2.0

238.9

53002

328344

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

237.3

7442

32273

H02AB04

ATC

methylprednisolone; systemic

1.6

236.8

6831

29045

L90

ICPC

Osteoarthrosis of knee

2.0

233.7

3071

10381

B01AF02

ATC

apixaban; oral

1.7

232.1

5391

21697

A04

ICPC

Weakness/tiredness general

1.6

231.2

6358

26712

SPAT1211

SPAT

Application of soft bandage

1.8

230.4

3937

14510

WZC30

NOMESCO Finland

Teaching

1.6

229.3

7451

32554

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

229.1

4015

14912

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

228.5

10888

51525

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

227.9

4627

17943

N06AB05

ATC

paroxetine; oral

2.0

227.9

2956

9945

R4190

NOMESCO Finland

Nutritional therapy

2.4

227.2

1859

5198

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.6

226.7

1561

4020

L01

ICPC

Neck symptom/complaint

1.6

226.7

7181

31185

M10

ICD-10 Finland

Gout

2.2

225.7

2104

6228

D07AC13

ATC

mometasone; topical

1.4

225.6

13785

68246

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

18.6

225.4

241

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

223.4

4436

17089

SJB60

NOMESCO Finland

Adjustment and grinding of removable appliance

5.1

222.8

554

705

N02BF02

ATC

pregabalin; oral

2.0

222.4

2843

9513

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

222.0

7325

32094

M01AX05

ATC

glucosamine; oral

1.5

221.7

8233

37014

A08AA62

ATC

bupropion and naltrexone; systemic

7.7

220.0

381

323

UDC00

NOMESCO Finland

Ear microscopy

1.9

219.6

3456

12406

B01AA03

ATC

warfarin; systemic

1.5

219.1

7724

34332

-1, ,

NOMESCO Finland

1.4

217.5

15436

78287

A10BJ01

ATC

exenatide; parenteral

4.6

217.4

602

846

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

216.4

1290

3082

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

215.1

5553

22939

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

214.5

11778

57125

SPAT1281

SPAT

Other administrative function

1.8

214.5

3572

13051

N05AX12

ATC

aripiprazole; systemic

2.3

214.3

1938

5661

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

214.0

2772

9316

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

213.0

10586

50400

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

211.7

3883

14607

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

211.5

2544

8323

RK250, ,

NOMESCO Finland

8.4

211.5

342

264

R35

ICD-10 Finland

Polyuria

1.9

210.9

3073

10753

R07.3

ICD-10 Finland

Other chest pain

1.7

210.7

4704

18706

3055, ,

Kela drug reimbursment

7.8

210.1

360

301

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.5

209.7

1556

4155

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

209.5

5273

21635

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

209.1

1481

3867

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

209.0

4093

15692

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

207.8

13677

68394

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

207.4

3757

14078

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

205.9

1182

2766

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

205.9

5869

24823

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

205.1

5599

23434

C09DA03

ATC

valsartan and diuretics; oral

2.1

204.0

2193

6874

E29.1

ICD-10 Finland

Testicular hypofunction

3.7

203.6

741

1297

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

203.2

4698

18848

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

202.3

5244

21663

A08

ICPC

Swelling

2.1

200.4

2239

7122

SPAT1229

SPAT

Assessment of need for aid

1.8

200.1

3318

12097

WX320

NOMESCO Finland

Spinalanesthesy

1.4

199.3

10956

53040

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

198.6

5174

21395

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.2

198.4

1834

5405

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

197.5

5878

25097

R74

ICPC

Upper respiratory infection acute

1.4

194.8

14573

74256

N05BA12

ATC

alprazolam; oral

1.7

194.6

4586

18481

EBA00

NOMESCO Finland

Extraction of tooth

1.3

193.2

16547

86080

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

193.1

3277

12030

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

193.1

16624

86547

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.3

191.2

580

881

A08AB01

ATC

orlistat; oral

5.4

190.6

447

537

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

190.3

2087

6589

SPAT1104

SPAT

Monitoring of emergency patient

1.9

188.6

2921

10416

TFP20

NOMESCO Finland

Cardiodefibrillation

1.8

188.5

3098

11257

J46

ICD-10 Finland

Status asthmaticus

2.5

188.4

1357

3571

SPAT1059

SPAT

Spirometry at the office

2.0

188.2

2336

7724

K07.4

ICD-10 Finland

Malocclusion, unspecified

3.2

188.1

853

1735

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

187.3

4986

20711

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

187.0

4511

18278

M02AA10

ATC

ketoprofen; topical

1.5

186.8

7193

32474

R03AC13

ATC

formoterol; inhalant

2.0

186.0

2291

7554

D07AD01

ATC

clobetasol; topical

1.5

185.6

7675

35150

C09BA02

ATC

enalapril and diuretics; systemic

1.8

185.4

3404

12791

C08CA02

ATC

felodipine; oral

1.7

185.4

3899

15230

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

185.3

212

A10BH05

ATC

linagliptin; oral

2.0

185.2

2174

7042

N06AX22

ATC

agomelatine; oral

2.7

184.4

1137

2765

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

183.2

7037

31741

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

181.8

8097

37616

SGA01

NOMESCO Finland

Emergency treatment

1.5

181.1

7770

35829

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

180.3

4254

17131

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

180.0

3480

13271

SPAT1254

SPAT

Administration of medicine

1.5

179.7

6073

26647

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

179.1

5476

23492

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

178.2

4103

16415

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

177.4

4086

16348

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

176.8

6184

27332

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

19.9

176.3

184

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

175.2

1877

5871

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

174.8

7985

37247

SPAT1139

SPAT

Nutrition survey

2.3

174.6

1453

4089

AN1

Coronary angiography

1.6

174.5

4485

18452

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

174.2

7962

37141

C09CA07

ATC

telmisartan; oral

1.7

174.1

3327

12641

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

173.5

3977

15888

G04BD08

ATC

solifenacin; oral

1.8

173.0

2806

10147

J02AC01

ATC

fluconazole; systemic

1.3

172.7

18365

98171

XF404

NOMESCO Finland

Ambulatory ECG

1.7

171.2

3807

15085

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

171.1

3965

15882

S29

ICPC

Skin symptom/complaint other

1.4

171.0

8444

39949

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.0

170.2

2008

6514

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

169.9

3813

15144

L14

ICPC

Leg/thigh symptom/complaint

1.7

169.9

3473

13448

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

169.8

9166

44059

ZXE00

NOMESCO Finland

One hour or less

1.3

169.8

17963

95895

R52.9

ICD-10 Finland

Pain, unspecified

1.6

169.1

4436

18336

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

169.0

16212

85347

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

167.9

1275

3440

SJB10

NOMESCO Finland

Fitting of removable appliance incl. patient instructions, demanding

6.9

167.3

313

293

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.6

167.1

4014

16225

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

167.0

3058

11471

R01AD11

ATC

triamcinolone; nasal

1.7

167.0

3949

15899

M01AH02

ATC

rofecoxib; oral

1.5

166.4

5477

23867

EB1VA, ,

NOMESCO Finland

1.5

166.3

5824

25721

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

166.1

1594

4768

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

165.9

11989

60469

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.0

165.8

547

889

M54

ICD-10 Finland

Dorsalgia

1.5

165.6

5650

24812

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.8

164.8

2931

10898

T07

ICPC

Weight gain

3.3

164.8

702

1371

H02AB07

ATC

prednisone; oral

1.5

164.4

6080

27161

L60.0

ICD-10 Finland

Ingrowing nail

2.0

163.5

2095

7001

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

163.1

12526

63748

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.6

162.5

3127

32782

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

162.5

1356

3820

A10BD07

ATC

metformin and sitagliptin; systemic

2.0

162.4

1911

6192

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

162.3

1413

4055

A10AB05

ATC

insulin aspart; parenteral

1.7

162.2

3363

13068

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

161.4

1522

4520

S76

ICPC

Skin infection other

1.9

161.0

2342

8173

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

160.7

10452

51792

L86

ICPC

Back syndrome with radiating pain

1.8

160.6

2707

9901

A10BG03

ATC

pioglitazone; oral

2.5

160.6

1131

2943

J45.8

ICD-10 Finland

Mixed asthma

2.3

160.2

1382

3950

F33

ICD-10 Finland

Recurrent depressive disorder

2.6

159.7

1039

2598

A10BB12

ATC

glimepiride; oral

1.8

159.6

2606

9438

K07

ICPC

Swollen ankles/oedema

2.0

159.3

1889

6137

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

159.2

3481

13720

S97

ICPC

Chronic ulcer skin

1.8

159.2

2532

9095

R06AX22

ATC

ebastine; oral

1.4

159.1

7882

37261

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

158.8

8067

38306

SAA04

NOMESCO Finland

Special examination of mouth

1.9

158.8

2281

7926

KMAK, ,

NOMESCO Finland

1.3

158.2

24961

139998

K86

ICPC

Hypertension uncomplicated

1.5

158.1

5302

23183

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

158.0

2550

9201

A02BC04

ATC

rabeprazole; oral

1.6

157.3

3956

16168

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

157.3

4140

17113

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

157.0

5071

21988

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

156.8

3630

14525

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

156.7

8739

42176

A01

ICPC

Pain general/multiple sites

1.6

156.7

3905

15922

XQ800

NOMESCO Finland

Prick test

1.7

156.7

3215

12453

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

156.5

2601

9471

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

156.4

1819

5867

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

155.8

7767

36744

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

155.8

4736

20255

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.1

155.5

1654

5156

K04.0

ICD-10 Finland

Pulpitis

1.6

155.0

4311

18056

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

154.9

3912

16004

I50.0

ICD-10 Finland

Congestive heart failure

1.8

153.5

2637

9698

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

153.4

2891

10929

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.2

153.3

1408

4135

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

152.6

2846

10725

SPAT1216

SPAT

Assessment of functional ability

1.5

151.9

6269

28600

OAA65, ,

SPAT

1.4

151.7

7217

33833

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

151.7

4512

42911

SPAT1043

SPAT

Audiometry

1.6

151.5

4109

17103

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

151.1

1182

3233

N06AX05

ATC

trazodone; oral

2.4

150.4

1173

3204

J01DA09

ATC

[U] cefadroxil

1.3

149.9

12232

62678

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

149.4

5824

26263

R06AE09

ATC

levocetirizine; oral

1.5

149.1

6374

29274

N06AG02

ATC

moclobemide; oral

2.0

148.5

1932

6488

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

148.4

4777

20681

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.6

148.4

961

2397

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

148.1

5348

23737

A11

ICPC

Chest pain NOS

1.7

147.8

3483

13994

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

147.5

2560

9442

N06AX03

ATC

mianserin; oral

1.9

147.5

2061

7093

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.6

147.3

3840

15825

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

146.9

1949

6589

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

146.7

2534

9332

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

146.3

2005

6854

C09DA07

ATC

telmisartan and diuretics; oral

2.0

145.9

1843

6124

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

145.6

5482

24536

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

145.4

5046

22203

S10

ICPC

Boil/carbuncle

1.8

145.2

2561

9491

XA421, ,

SPAT

4.5

144.9

415

601

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.4

144.6

1176

3274

B01AC04

ATC

clopidogrel; oral

1.4

144.6

6545

30377

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

144.5

3217

12730

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

144.2

4207

17806

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

144.1

4289

18236

R13

ICD-10 Finland

Dysphagia

1.7

143.8

2905

11195

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

143.7

1854

6206

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

143.6

3315

13243

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

143.5

5032

22185

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

143.5

2823

10798

OAB42, ,

SPAT

1.6

143.4

4249

18048

H02

ICPC

Hearing complaint

1.5

143.0

5621

25375

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

142.6

5100

22577

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.2

142.4

1416

4296

C05AA08

ATC

fluocortolone; rectal, topical

1.5

140.6

6095

28043

R5110, ,

SPAT

1.7

140.1

2702

10276

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

140.1

3981

16742

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

139.9

4389

18882

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

2.5

139.7

1004

2638

J01FA15

ATC

telithromycin; oral

1.5

139.2

4450

19222

P01

ICPC

Feeling anxious/nervous/tense

1.5

138.9

4545

19735

R28

ICPC

Limited function/disability (R)

3.2

138.9

627

1272

D07XC01

ATC

betamethasone; topical

1.5

138.8

5257

23545

358

Kela drug reimbursment

liraglutide

5.7

138.7

310

355

C07AB12

ATC

nebivolol; oral

2.2

138.3

1339

4018

SPAT1053

SPAT

Memory test

1.5

138.1

5393

24302

K30

ICD-10 Finland

Functional dyspepsia

1.5

138.0

4928

21802

R03DA04

ATC

theophylline; systemic, rectal

1.9

138.0

1944

6707

K85

ICPC

Elevated blood pressure

1.4

137.9

6642

31161

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

5.4

137.5

323

389

RD210, ,

NOMESCO Finland

2.8

137.3

801

1890

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

136.9

13392

70249

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

136.6

1047

2836

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

136.4

5776

26444

C10AA03

ATC

pravastatin; oral

1.7

136.4

2862

11142

D11

ICPC

Diarrhoea

1.5

136.3

5010

22294

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

135.8

1461

4572

SPAT1325

SPAT

Vaccination

1.3

135.4

14191

75110

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

135.3

2345

8641

C07AA05

ATC

propranolol; systemic

1.4

135.1

8983

44509

N05BA01

ATC

diazepam; systemic, rectal

1.5

134.5

5578

25430

WX002

NOMESCO Finland

Sedation and analgesia

1.4

134.4

8355

40947

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.6

134.4

882

2215

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

134.3

1119

3149

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

134.2

14281

75721

OAB93, ,

SPAT

1.7

133.9

2559

9703

N03AE01

ATC

clonazepam; systemic

1.8

133.6

2451

9184

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.5

133.6

965

2541

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

133.4

6986

33255

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

133.2

3270

13263

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

133.2

2595

9894

W78

ICPC

Pregnancy

0.5

132.3

1117

15003

R03AC12

ATC

salmeterol; inhalant

1.9

131.8

1830

6282

A99

ICPC

Disease/condition unspecnature/site

1.6

131.5

3880

16451

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.0

131.1

1499

4801

L29

ICPC

Musculoskeletal sympt/complt other

1.6

131.0

3588

14948

ZY010

NOMESCO Finland

Hospital outpatient

1.8

130.8

2127

7684

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

130.8

3065

12283

WX402

NOMESCO Finland

General anaesthesia

1.3

130.8

9557

48022

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.7

130.6

2791

10916

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

130.2

12321

64257

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

129.0

1830

6326

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

129.0

9527

47936

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

128.7

3442

14255

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

128.7

2429

9176

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

128.7

2963

11820

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

128.3

1242

3726

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

127.8

6672

31721

I50

ICD-10 Finland

Heart failure

2.3

127.8

1108

3173

M10.0

ICD-10 Finland

Idiopathic gout

2.1

127.4

1421

4509

MAX99

NOMESCO Finland

Assistance to normal delivery

0.4

127.0

638

10498

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

126.8

2534

9729

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.0

126.2

1516

4945

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

126.2

3175

12953

H02.3

ICD-10 Finland

Blepharochalasis

1.7

126.0

2663

10382

J01MA14

ATC

moxifloxacin; systemic

1.6

125.9

3838

16387

XG405

NOMESCO Finland

Education on PEF monitoring

2.9

125.8

686

1559

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

125.0

2976

11972

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

125.0

2038

7368

M01AB01

ATC

indometacin; systemic, rectal

1.6

124.3

2950

11857

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

124.1

9613

48674

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

124.1

1476

4797

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

123.7

10929

56392

R00.2

ICD-10 Finland

Palpitations

1.6

123.4

3289

13606

A10AE05

ATC

insulin detemir; parenteral

1.8

122.8

2237

8362

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

122.4

2604

10169

G04CB01

ATC

finasteride; oral

1.5

121.8

4182

18322

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

121.6

3726

15923

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

121.4

2413

9248

D01AE15

ATC

terbinafine; topical

1.6

120.6

2983

12113

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

120.4

9864

50325

N06AA12

ATC

doxepin; systemic

1.8

120.2

2090

7704

R04.2

ICD-10 Finland

Haemoptysis

2.0

119.9

1398

4510

K05.30

ICD-10 Finland

Periodontitis complex

1.4

119.6

6214

29493

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.2

119.5

1152

3450

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

119.5

1656

5679

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

119.3

4890

22209

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

119.1

2337

8922

L12

ICPC

Hand/finger symptom/complaint

1.4

118.8

6868

33194

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

118.4

6367

30395

N06BA04

ATC

methylphenidate; oral

2.2

118.0

1133

3388

C09DB01

ATC

valsartan and amlodipine; oral

2.0

117.6

1420

4639

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

117.6

1905

6872

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

117.4

2251

8538

D01AC03

ATC

econazole; topical

1.7

117.4

2463

9580

K80

ICPC

Cardiac arrhythmia NOS

1.6

117.2

3321

13935

U04

ICPC

Incontinence urine

1.8

116.8

1997

7323

L02

ICPC

Back symptom/complaint

1.5

116.8

4152

18318

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

116.8

1771

6256

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

116.6

2896

11770

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

116.5

4404

19676

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

116.2

3002

12320

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.9

116.0

1576

5367

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

115.8

4586

20682

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

115.1

2543

10028

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

114.9

1678

5854

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

114.9

2527

9952

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

114.8

6546

31549

K04.08

ICD-10 Finland

Other specified pulpit

1.6

114.2

3282

13813

D01AC02

ATC

miconazole; topical

1.6

114.2

3108

12916

J01CF05

ATC

flucloxacillin; systemic

1.7

113.8

2532

10002

ZXA10

NOMESCO Finland

Bilateral

1.4

113.8

7691

38090

I20.09

ICD-10 Finland

Unstable angina

1.7

113.6

2132

8036

SPAT1238

SPAT

Brief therapy

2.6

113.2

759

1927

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

113.1

11358

59516

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.5

113.1

808

2117

3478X

ICD-9 Finland

Cataplexy and narcolepsy[MUUT ORGANISET UNIHÄIRIÖT]

+∞

112.7

129

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

112.7

4304

19264

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

112.4

2173

8259

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

112.1

4724

21559

SPAT1197

SPAT

Extensive health check-up of expecting family

0.5

111.9

1016

13329

P29

ICPC

Psychological sympt/compl other

1.6

111.8

2702

10903

SPAT1255

SPAT

Intravenous administration of medicine

1.6

111.6

2797

11390

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

111.0

1996

7429

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

110.6

3289

13950

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.5

110.6

771

1996

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.8

110.5

634

1483

GX2C5

NOMESCO Finland

Short-lasting oximetry

5.4

110.3

259

312

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

110.2

11148

58439

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.6

109.7

1791

19702

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

109.4

3145

13233

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

109.3

1839

6709

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.7

109.2

400

704

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

109.2

2293

8916

N17

ICPC

Vertigo/dizziness

1.4

108.9

4792

22043

M76.6

ICD-10 Finland

Achilles tendinitis

1.7

108.9

2135

8147

A03

ICPC

Fever

1.4

108.8

7047

34647

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

108.8

4064

18104

S21

ICPC

Skin texture symptom/complaint

1.4

108.7

5868

27998

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.1

108.5

1136

3516

C07AG02

ATC

carvedilol; oral

1.7

108.4

2234

8642

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

4.7

108.4

292

401

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

108.3

3868

17069

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.5

108.2

1206

14808

Z71.8

ICD-10 Finland

Other specified counselling

1.3

108.2

13536

72842

A10AC01

ATC

insulin (human); parenteral

1.6

107.5

2928

12164

A08AA10

ATC

sibutramine; oral

5.9

107.2

232

257

S80.0

ICD-10 Finland

Contusion of knee

1.6

107.1

3073

12925

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

107.0

1903

7060

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.9

106.6

1516

5243

A06AC51

ATC

ispaghula, combinations; oral

1.7

106.4

1993

7506

D19

ICPC

Teeth/gum symptom/complaint

1.3

106.0

12470

66573

A10BD20

ATC

metformin and empagliflozin; oral

2.8

106.0

610

1429

F61.0

ICD-10 Finland

Mixed personality disorders

2.5

105.4

778

2070

C03BA11

ATC

indapamide; oral

2.1

105.3

1107

3432

R01AD05

ATC

budesonide; nasal

1.5

105.3

3209

13682

M54.2

ICD-10 Finland

Cervicalgia

1.5

104.6

3328

14324

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

104.5

2306

9085

J01DA06

ATC

[U] cefuroxime

1.4

104.3

6129

29650

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

104.1

5507

26173

H13

ICPC

Plugged feeling ear

1.3

103.8

7879

39652

R52.2

ICD-10 Finland

Other chronic pain

1.9

103.7

1507

5249

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.5

103.6

758

2009

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.6

103.5

2430

9729

Z3226

NOMESCO Finland

Physiotherapist

1.3

103.3

7623

38203

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

103.1

1823

19654

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.2

103.0

323

505

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.0

102.9

508

1090

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.5

102.6

1183

14381

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

102.6

1207

3906

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

102.6

1617

5781

WZC00, ,

SPAT

1.5

102.4

4043

18200

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

102.4

4032

18143

H29

ICPC

Ear symptom/complaint other

1.4

102.2

4647

21491

H81

ICPC

Excessive ear wax

1.4

102.1

6998

34676

R51

ICD-10 Finland

Headache

1.7

102.0

2266

8943

M15

ICD-10 Finland

Polyarthrosis

1.7

101.9

1940

7340

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.7

101.8

635

1554

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

101.7

8293

42155

R04.0

ICD-10 Finland

Epistaxis

1.6

101.6

2902

12189

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.2

101.5

979

2933

X58

ICD-10 Finland

Exposure to other specified factors

1.4

101.4

6154

29915

K03.66

ICD-10 Finland

Tooth plaque

1.6

101.1

2961

12507

SPAT1359

SPAT

Use of symptom diary

2.1

101.0

1070

3328

R31

ICD-10 Finland

Unspecified haematuria

1.5

100.9

4041

18241

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

100.8

1901

7172

N07BA03

ATC

varenicline; oral

1.7

100.6

2129

8293

N06AX18

ATC

reboxetine; oral

3.0

100.6

521

1150

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

100.6

13867

75353

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

100.5

2835

11871

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

100.4

8587

43935

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

99.9

2326

9292

R5140, ,

SPAT

3.2

99.8

444

893

G04CB02

ATC

dutasteride; oral

1.6

99.6

2808

11755

R50.9

ICD-10 Finland

Fever, unspecified

1.4

99.2

6223

30403

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.6

99.0

649

1629

RK123, ,

NOMESCO Finland

45.4

98.8

HMAK, ,

NOMESCO Finland

1.4

98.7

4923

23146

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

98.5

2319

9290

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

98.3

2859

12055

D01

ICPC

Abdominal pain/cramps general

1.4

98.2

4613

21455

P20

ICPC

Memory disturbance

1.4

98.1

4739

22153

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

98.1

3360

14689

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.6

98.0

1693

18375

R06.3

ICD-10 Finland

Periodic breathing

7.3

97.9

175

155

N02AJ13

ATC

tramadol and paracetamol; systemic

2.1

97.7

981

2987

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.9

97.2

1353

4645

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.4

97.1

4174

19094

SPAT1054

SPAT

Examination of peripheral nervous system

2.4

97.1

718

1913

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.4

96.9

552

8629

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.3

96.5

423

843

S22

ICPC

Nail symptom/complaint

1.6

96.4

2555

10540

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.0

96.4

1180

3874

R06AX13

ATC

loratadine; oral

1.4

96.3

6312

31039

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.1

96.3

454

947

N05CD07

ATC

temazepam; oral

1.4

96.2

4436

20557

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

95.9

2478

10160

Z00.0

ICD-10 Finland

General medical examination

1.3

95.5

8061

41136

Z37.0

ICD-10 Finland

Single live birth

0.5

95.3

955

12139

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

95.1

2935

12541

N03AG01

ATC

valproic acid; systemic, rectal

1.6

95.0

2479

10186

WZA00

NOMESCO Finland

Concise certificate

1.6

95.0

2610

10858

B35.3

ICD-10 Finland

Tinea pedis

1.7

94.8

1855

7070

SPAT1380

SPAT

Postpartum check-up

0.4

94.8

521

8269

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

94.4

1158

3804

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

94.4

5035

23939

M01AC01

ATC

piroxicam; systemic, rectal

1.4

94.3

5412

26047

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

94.3

1430

5049

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.5

94.2

684

1806

J02AC02

ATC

itraconazole; systemic

1.3

93.9

7673

38970

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

93.8

2666

11179

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

93.5

2368

9659

E000001, ,

ATC

1.3

93.4

8260

42409

H01

ICPC

Ear pain/earache

1.4

93.3

4562

21361

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.4

93.2

750

2078

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

92.7

1246

4227

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

19.6

92.6

SPAT1283

SPAT

Restricted health certificate

1.3

92.5

6958

34914

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

92.2

4159

19189

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.9

92.2

1255

4276

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

92.0

1383

4868

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

92.0

3326

14696

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.5

92.0

637

1644

R73

ICD-10 Finland

Elevated blood glucose level

1.9

91.8

1230

4167

C10AA04

ATC

fluvastatin; oral

1.5

91.8

3117

13595

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

91.6

4445

20781

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

182.2

91.3

112

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

91.1

745

2079

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.0

91.1

1080

3504

Z2445

NOMESCO Finland

Psychologist

1.8

91.0

1509

5478

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.0

91.0

304

500

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

3.6

90.9

341

611

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.7

90.8

1826

7013

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

90.3

1044

3356

RK110, ,

NOMESCO Finland

3.6

90.2

345

627

R12

ICD-10 Finland

Heartburn

1.5

90.1

3313

14688

SFA00

NOMESCO Finland

Small restoration

1.4

90.0

5865

28791

K78

ICPC

Atrial fibrillation/flutter

1.5

89.9

2750

11724

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

89.8

1974

7765

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

89.8

3162

13896

A03FA02

ATC

cisapride; oral, rectal

1.5

89.7

2830

12147

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

89.6

1326

4644

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

89.5

1919

7498

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

89.1

3051

13327

KGH10

NOMESCO Finland

Operation for phimosis

2.0

88.9

1084

3553

N03AX11

ATC

topiramate; oral

2.0

88.8

1006

3209

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.9

88.8

483

1097

K07.13

ICD-10 Finland

Retrognaty, mandibular

2.7

88.6

550

1343

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

88.4

1673

6315

GD1AA, ,

SPAT

1.4

88.4

5080

24441

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.7

88.2

1810

6990

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.7

88.1

1782

6854

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

88.0

1297

4536

N06AA10

ATC

nortriptyline; systemic

2.1

88.0

895

2739

T92

ICPC

Gout

2.2

87.8

790

2299

DAX08

NOMESCO Finland

Fitting of hearing aid

1.7

87.7

1918

7534

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

1.6

87.6

2105

8472

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

87.4

3119

13743

D02AE01

ATC

carbamide; topical

1.6

87.2

2563

10827

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.6

87.2

2350

9729

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

87.1

4089

18997

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.7

87.0

1730

6622

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

86.8

4001

18524

N05BE01

ATC

buspirone; oral

1.9

86.7

1209

4152

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

86.6

2667

11383

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

86.5

2775

11953

N62

ICD-10 Finland

Hypertrophy of breast

1.7

86.1

1684

6416

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

85.8

808

2397

R03BC03

ATC

nedocromil; inhalant

1.5

85.5

2762

11913

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.7

85.2

1678

6406

M01AB55

ATC

diclofenac, combinations; oral

1.6

84.9

2514

10635

M54.1

ICD-10 Finland

Radiculopathy

1.7

84.7

1640

6231

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.6

84.6

1964

7836

H02AB09

ATC

hydrocortisone; systemic

2.0

84.5

955

3044

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

84.5

3809

17562

R21

ICPC

Throat symptom/complaint

1.3

84.2

8359

43509

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

84.2

1120

3786

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.0

84.1

1019

3332

SPAT1379

SPAT

Health check-up of pregnant person

0.5

84.0

762

10020

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.4

84.0

632

1698

K08.80

ICD-10 Finland

Toothache NOS

1.4

83.6

3613

16525

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

83.5

2673

11506

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

5.0

83.0

209

270

M01AB08

ATC

etodolac; oral

1.5

83.0

2911

12776

S06.0

ICD-10 Finland

Concussion

1.4

82.5

4269

20165

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

82.4

2526

10770

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

82.4

4093

19200

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.6

82.1

2314

9677

R95

ICPC

Chron obstructive pulmonary disease

1.9

82.1

1082

3645

H60

ICD-10 Finland

Otitis externa

1.6

81.8

2101

8594

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.9

81.6

1208

4231

H25.8

ICD-10 Finland

Other senile cataract

1.4

81.3

3713

17156

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.3

81.2

657

1825

C01BC04

ATC

flecainide; systemic

1.8

81.2

1346

4886

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

2.0

81.2

964

3130

S01

ICPC

Pain/tenderness of skin

1.7

81.2

1782

7006

R78

ICPC

Acute bronchitis/bronchiolitis

2.1

81.1

855

2654

C08DB01

ATC

diltiazem; oral

1.7

80.8

1690

6558

FN1AD

NOMESCO Finland

CT of coronary arteries

2.2

80.7

743

2183

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

80.7

2479

10571

N01

ICPC

Headache

1.4

80.7

3923

18327

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

11.9

80.7

105

-31

ICPC

Medical examin/health eval partial

1.5

80.5

2544

10917

EB4VA, ,

NOMESCO Finland

1.4

80.4

4470

21368

XKC03

NOMESCO Finland

Water cystometry

1.9

80.2

1165

4055

N02AA05

ATC

oxycodone; systemic

1.3

80.2

6755

34379

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

80.2

2666

11566

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

80.2

2717

11836

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

80.1

1454

5422

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

80.1

900

2863

IHZ05, ,

SPAT

1.8

80.1

1242

4416

D05AX52

ATC

calcipotriol, combinations; topical

1.6

80.0

2258

9447

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

79.9

2504

10725

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.0

79.7

259

417

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.8

79.7

1339

4880

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.2

79.6

710

2059

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.9

79.5

1167

4076

A97

ICPC

No disease

1.3

79.2

7160

36784

G04BD07

ATC

tolterodine; oral

1.7

79.2

1694

6614

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

78.9

2248

9424

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

78.6

5054

24725

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

78.6

3402

15560

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

78.6

852

2674

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.4

78.3

4674

22602

ZXD05

NOMESCO Finland

Urgent procedure

1.2

78.2

12945

71366

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

77.5

2010

8241

SPAT1266

SPAT

Separate instruction to prepare for procedure

1.9

77.4

1065

3642

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

77.3

10273

55302

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

77.2

3667

17058

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.7

77.2

1747

6923

N06AX17

ATC

milnacipran; oral

2.7

77.0

481

1179

J01MA01

ATC

ofloxacin; systemic

1.5

76.9

3139

14195

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.4

76.8

4425

21271

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.0

76.8

985

3288

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.0

76.7

972

3231

RK510, ,

NOMESCO Finland

10.0

76.7

110

R55

ICD-10 Finland

Syncope and collapse

1.4

76.6

4172

19867

NG2AA

NOMESCO Finland

Patella X-ray examination

1.9

76.6

1057

3617

NG1AA, ,

SPAT

1.5

76.5

2841

12611

R01AD59

ATC

mometasone, combinations; nasal

1.7

76.3

1578

6105

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

76.2

2254

9530

M54.3

ICD-10 Finland

Sciatica

1.5

76.1

2394

10262

C10AB05

ATC

fenofibrate; oral

2.2

76.1

740

2225

NOMESCO Finland

Other rehabilitation services

576.4

75.9

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

75.8

2803

12431

E66.1

ICD-10 Finland

Drug-induced obesity

5.7

75.8

167

189

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.1

75.7

790

2443

Z00.8

ICD-10 Finland

Other general examinations

1.5

75.6

3079

13918

K03.00

ICD-10 Finland

Approximal wear

1.5

75.5

2799

12418

D01AE16

ATC

amorolfine; topical

1.4

75.3

4666

22689

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

75.1

3644

17009

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.1

75.1

770

2365

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.9

75.0

1133

3994

C08DA01

ATC

verapamil; systemic

1.7

75.0

1485

5676

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

75.0

4830

23626

N05AN01

ATC

lithium; oral

1.9

74.8

970

3250

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

74.7

643

1836

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

74.4

1294

4765

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

4.7

74.3

200

275

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

74.2

2195

9279

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.5

74.2

560

7858

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.4

74.2

573

1559

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.1

74.0

793

2478

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

73.9

3037

13749

SCA02

NOMESCO Finland

Preventive oral health care

1.4

73.6

3773

17779

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

73.5

1699

6768

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

73.5

2021

8401

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

73.5

2322

9961

N48.1

ICD-10 Finland

Balanoposthitis

1.9

73.5

1004

3425

D07AB08

ATC

desonide; topical

1.4

73.5

4247

20420

SGC10

NOMESCO Finland

Pulp capping

1.4

73.3

3554

16584

AA43B, ,

NOMESCO Finland

147.5

73.3

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.8

73.0

1194

4316

M77.4

ICD-10 Finland

Metatarsalgia

1.5

72.8

2387

10322

J01DC02

ATC

cefuroxime; systemic

1.5

72.7

2201

9352

N06AA06

ATC

trimipramine; systemic

2.0

72.4

934

3124

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.3

72.3

636

1834

QBJ30

NOMESCO Finland

Correction of abdominal apron

3.0

72.1

367

803

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.0

72.0

848

2745

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

71.9

2105

8877

R4180, ,

SPAT

2.8

71.8

397

911

M01AH03

ATC

valdecoxib; oral

1.5

71.7

2447

10671

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

71.6

714

2169

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.7

71.5

1465

5653

R05DA01

ATC

ethylmorphine; oral

1.4

70.9

3066

14010

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

70.9

1571

6189

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.9

70.8

1012

3504

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.7

70.8

435

1057

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.5

70.4

2621

11634

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

70.4

3664

17305

C09AA04

ATC

perindopril; oral

1.6

70.4

1872

7719

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

70.4

11350

62284

A08AA02

ATC

fenfluramine; oral

2.8

70.4

388

889

A02BA04

ATC

nizatidine; systemic

1.5

70.2

2782

12505

A06AD11

ATC

lactulose; oral

1.3

69.7

5256

26302

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.0

69.7

865

2854

N06BA07

ATC

modafinil; oral

4.9

69.7

181

241

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

69.6

1916

7966

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

69.6

6566

33873

P99

ICPC

Psychological disorders other

1.8

69.6

1130

4076

L04

ICPC

Chest symptom/complaint

1.5

69.6

2382

10394

Z3232

NOMESCO Finland

Midwife

0.5

69.5

940

10926

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

69.5

2891

13114

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

69.4

1395

5354

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

69.2

6131

31366

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.3

69.1

600

1720

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.1

69.1

688

2089

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

69.1

1332

5054

SPAT1243

SPAT

Psychiatric/psychological examination

1.9

69.1

939

3198

SPAT1252

SPAT

Overall medication plan or its review

1.5

69.0

2472

10887

K07.60

ICD-10 Finland

Snapping jaw

1.6

69.0

1933

8069

F50.8

ICD-10 Finland

Other eating disorders

4.8

68.8

181

244

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.9

68.6

1003

3499

M09AX01

ATC

hyaluronic acid; parenteral

1.6

68.5

1628

6531

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

68.5

1974

8295

A05

ICPC

Feeling ill

1.6

68.4

2025

8560

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.3

68.2

591

1693

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

68.2

1123

4068

N06AB08

ATC

fluvoxamine; oral

1.8

68.2

1056

3753

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.3

68.0

557

1557

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

67.8

1665

6733

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.0

67.8

775

2482

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.5

67.8

2610

11663

N48.4

ICD-10 Finland

Impotence of organic origin

1.9

67.6

913

3102

G04BD11

ATC

fesoterodine; oral

1.8

67.5

1037

3676

H60.8

ICD-10 Finland

Other otitis externa

1.8

67.5

1166

4286

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

67.4

1337

5112

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

67.3

2140

9190

A10BH02

ATC

vildagliptin; oral

2.1

67.3

699

2158

S22.3

ICD-10 Finland

Fracture of rib

1.5

67.2

2753

12449

D75.1

ICD-10 Finland

Secondary polycythaemia

3.3

67.2

282

547

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

67.2

1993

8429

SPAT1360

SPAT

Extensive global examination

1.5

67.1

2677

12044

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.8

66.9

1057

3781

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

66.6

1663

6753

B01AE07

ATC

dabigatran etexilate; oral

1.7

66.6

1375

5316

RK520, ,

NOMESCO Finland

4.2

66.5

204

314

Z01.7

ICD-10 Finland

Laboratory examination

1.3

66.2

5868

30008

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.8

66.2

385

909

C01CA24

ATC

epinephrine; parenteral

1.5

66.1

2404

10618

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

65.9

2303

10091

L30.4

ICD-10 Finland

Erythema intertrigo

2.3

65.8

559

1588

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

65.7

1333

5130

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.8

65.6

1026

3657

M19.8

ICD-10 Finland

Other specified arthrosis

1.7

65.6

1465

5784

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.0

65.6

809

2664

XG460

NOMESCO Finland

Short time oxymetry

2.3

65.5

546

1538

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.1

65.4

707

2217

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

65.3

1869

7840

F32.0

ICD-10 Finland

Mild depressive episode

1.8

65.2

1024

3655

D06

ICPC

Abdominal pain localized other

1.4

65.1

3262

15301

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

65.1

3488

16549

A10AE06

ATC

insulin degludec; parenteral

1.7

65.1

1344

5197

A10BX01

ATC

guar gum; oral

1.7

65.0

1203

4511

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

64.9

2833

12963

F31

ICD-10 Finland

Bipolar affective disorder

2.4

64.7

506

1385

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

64.7

1900

8016

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

64.6

987

3492

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

64.6

893

3058

C01AA05

ATC

digoxin; systemic

1.5

64.6

2333

10291

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

64.4

2916

13432

E03

ICD-10 Finland

Other hypothyroidism

1.5

64.2

2256

9894

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

64.2

1459

5786

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

64.2

5168

26084

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.0

64.2

757

2453

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.3

64.0

170

3822

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.3

63.8

521

1455

UDM02

NOMESCO Finland

Sinoscopy

1.9

63.7

872

2977

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

63.5

8318

44581

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

0.6

63.3

1077

11770

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

63.2

5643

28877

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.9

63.0

914

3181

-45

ICPC

Observ/health educat/advice/diet

1.7

63.0

1145

4272

F32.8

ICD-10 Finland

Other depressive episodes

2.2

62.9

601

1795

N39.3

ICD-10 Finland

Stress incontinence

1.4

62.9

2728

12468

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

62.8

16423

94087

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

2.3

62.8

538

1534

D02

ICPC

Abdominal pain epigastric

1.5

62.8

2281

10071

K29

ICPC

Cardiovascular sympt/complt other

1.6

62.7

1582

6440

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.1

62.6

628

1913

N05AA02

ATC

levomepromazine; systemic

1.6

62.6

1510

6080

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

62.4

6030

31168

R11

ICD-10 Finland

Nausea and vomiting

1.4

62.4

3111

14577

UJD02

NOMESCO Finland

Gastroscopy

1.6

62.3

1737

7241

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.7

62.3

1378

5427

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.3

62.3

525

1487

S04

ICPC

Lump/swelling localized

1.4

62.1

3932

19155

L05

ICPC

Flank/axilla symptom/complaint

1.5

62.0

2266

10016

L73.2

ICD-10 Finland

Hidradenitis suppurativa

2.5

62.0

424

1089

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.8

61.8

1021

3702

M65.3

ICD-10 Finland

Trigger finger

1.6

61.8

1780

7476

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

61.7

1624

6678

AA40C, ,

NOMESCO Finland

86.4

61.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

61.6

3629

17483

C07BB07

ATC

bisoprolol and thiazides; systemic

1.7

61.4

1376

5436

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.7

61.4

1349

5302

G04BD09

ATC

trospium; oral

1.9

61.4

860

2959

C07AB08

ATC

celiprolol; oral

1.9

61.3

858

2952

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.1

61.2

292

615

P74

ICPC

Anxiety disorder/anxiety state

1.6

61.1

1439

5758

J01

ICD-10 Finland

Acute sinusitis

1.5

61.0

2095

9143

N07CA01

ATC

betahistine; oral

1.4

61.0

2693

12348

M75

ICD-10 Finland

Shoulder lesions

1.6

60.8

1720

7195

R06AX26

ATC

fexofenadine; oral

1.4

60.8

2678

12273

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.6

60.8

383

944

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.8

60.6

1026

3748

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

60.5

2142

9407

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.8

60.5

1029

3765

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

60.3

1540

6287

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

60.3

4715

23689

F29

ICPC

Eye symptom/complaint other

1.4

60.2

3623

17509

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.4

60.2

2828

13112

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

60.1

2663

12216

R07

ICPC

Sneezing/nasal congestion

1.5

60.1

2383

10705

CL2S4, ,

SPAT

2.2

60.0

558

1648

ECB00

NOMESCO Finland

Suture of gingiva

1.6

60.0

1395

5564

Z2446

NOMESCO Finland

Social worker

1.5

60.0

2359

10580

C09AA03

ATC

lisinopril; oral

1.6

60.0

1595

6576

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.5

59.8

2456

11107

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.5

59.7

2052

8956

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

59.6

1377

5484

D07AA02

ATC

hydrocortisone; topical

1.3

59.6

5369

27494

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.7

59.4

1286

5035

ZXC10

NOMESCO Finland

Use of laser

1.9

59.2

835

2879

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

59.2

11064

61433

S06

ICPC

Rash localized

1.5

59.2

2070

9068

ZYC01, ,

SPAT

1.4

59.1

3367

16127

WW200, ,

SPAT

1.2

59.0

9506

52022

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

59.0

1290

5065

CK2S4, ,

SPAT

2.2

58.9

532

1552

XA800

NOMESCO Finland

Neuropsychological investigation

1.6

58.8

1632

6796

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.0

58.8

732

2419

H02.4

ICD-10 Finland

Ptosis of eyelid

1.8

58.8

1063

3960

Y28

ICPC

Limited function/disability (Y)

3.8

58.6

204

347

L11

ICPC

Wrist symptom/complaint

1.4

58.6

3286

15701

K11.2

ICD-10 Finland

Sialoadenitis

1.7

58.4

1242

4841

G47

ICD-10 Finland

Sleep disorders

5.2

58.4

140

173

MA3AE

NOMESCO Finland

Combined first trimester screening

0.3

58.3

176

3695

SGB30

NOMESCO Finland

Other complicated root filling

1.3

58.3

4809

24335

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

58.1

13621

77184

WVA30, ,

SPAT

1.5

58.1

2033

8907

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.7

58.1

1233

4803

R03BB01

ATC

ipratropium bromide; inhalant

1.7

57.9

1193

4611

U02

ICPC

Urinary frequency/urgency

1.3

57.6

5208

26670

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.7

57.6

348

839

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

57.6

4918

24998

C10AC01

ATC

colestyramine; oral

1.8

57.3

1022

3792

B01AB10

ATC

tinzaparin; parenteral

1.3

57.3

3907

19241

-50

ICPC

Medication/prescr/renewal

1.6

57.2

1452

5919

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

0.6

56.9

1324

13427

A29

ICPC

General symptom/complaint other

1.3

56.9

4730

23955

SPAT1057

SPAT

Peak expiratory flow measurement

1.9

56.9

825

2872

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.0

56.6

720

2398

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

56.5

1705

7236

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

1.8

56.5

983

3621

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.1

56.4

270

570

I50.1

ICD-10 Finland

Left ventricular failure

1.6

56.4

1552

6450

K08.3

ICD-10 Finland

Retained dental root

1.4

56.3

2959

13985

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.6

56.3

1522

6300

A10BX09

ATC

[U] dapagliflozin

2.6

56.2

355

876

M01AX01

ATC

nabumetone; oral

1.6

56.2

1552

6455

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

56.0

1134

4362

S02CA02

ATC

flumetasone and antiinfectives; otic

1.5

55.9

1966

8622

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

55.9

1677

7109

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

2.8

55.8

310

714

J05AB01

ATC

aciclovir; systemic

1.2

55.8

8909

48678

C08CA10

ATC

nilvadipine; oral

2.0

55.7

674

2205

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.9

55.7

827

2901

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.8

55.7

906

3271

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

55.6

1183

4611

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

2.3

55.6

477

1362

L18

ICPC

Muscle pain

1.6

55.4

1519

6307

JAF10

NOMESCO Finland

Repair of umbilical hernia

1.8

55.3

845

2991

N06AA04

ATC

clomipramine; systemic

2.0

55.2

642

2070

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.4

55.2

2483

11419

-48

ICPC

Clarification/discussion RFE/demand

1.9

55.1

813

2846

Angiography of the heart and coronary arteries

1.5

55.1

1916

8383

NF1DA

NOMESCO Finland

X-ray of hips

1.9

55.1

771

2653

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

2.5

55.1

388

1012

M54.8

ICD-10 Finland

Other dorsalgia

1.5

55.0

1681

7154

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.0

55.0

697

2318

U07

ICPC

Urine symptom/complaint other

1.4

55.0

2670

12447

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.0

55.0

645

2087

S82

ICPC

Naevus/mole

1.3

54.9

5145

26459

N07BB01

ATC

disulfiram; oral

1.5

54.9

1737

7448

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

54.9

1121

4321

C01BD01

ATC

amiodarone; systemic

1.7

54.8

994

3706

N20.1

ICD-10 Finland

Calculus of ureter

1.6

54.7

1411

5774

R49.01

ICD-10 Finland

Functional dysphonia

1.7

54.7

1097

4208

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.6

54.7

1260

5015

J30.3

ICD-10 Finland

Other allergic rhinitis

1.6

54.6

1311

5273

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

1.9

54.6

748

2556

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

54.5

2162

9711

WX781

NOMESCO Finland

Remote monitoring, noninvasive ventilation

16.5

54.5

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.8

54.5

964

3569

K07.23

ICD-10 Finland

Deep bite

2.0

54.4

680

2250

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

54.4

1675

7140

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

54.4

2419

11101

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

54.3

1253

4988

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

54.3

1113

4295

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

54.3

1797

7782

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

54.2

1485

6164

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.8

54.1

306

712

M02AA15

ATC

diclofenac; topical

1.4

53.9

2749

12922

RK290, ,

NOMESCO Finland

5.0

53.9

137

179

ZXA00

NOMESCO Finland

Right side

1.2

53.9

10651

59368

N05AH03

ATC

olanzapine; systemic

1.4

53.9

2367

10838

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

53.8

5121

26384

A12BA01

ATC

potassium chloride; oral

1.7

53.8

1207

4770

R60.1

ICD-10 Finland

Generalized oedema

2.8

53.8

295

675

T99

ICPC

Endocr/metab/nutrit disease other

2.1

53.6

579

1816

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.6

53.6

1276

5120

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.7

53.6

1073

4114

P25

ICPC

Phase of life problem adult

1.6

53.5

1499

6255

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.4

53.4

400

1074

K02.2

ICD-10 Finland

Caries of cementum

1.5

53.4

1708

7341

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.5

53.1

1559

6575

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

53.1

8292

45175

TFP34

NOMESCO Finland

Electrophysiological investigation

1.7

53.1

1107

4292

TGC00

NOMESCO Finland

Bronchial lavation

1.8

53.0

944

3502

C05AA01

ATC

hydrocortisone; rectal, topical

1.5

52.9

1873

8225

ENC99

NOMESCO Finland

Other reconstructive operation on pharynx and adjacent structures

7.5

52.9

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

52.9

1748

7567

K04

ICPC

Palpitations/awareness of heart

1.5

52.8

1895

8343

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.4

52.8

2248

10233

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

52.8

6967

37295

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

52.7

2819

13358

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.7

52.7

1067

4104

A10AB06

ATC

insulin glulisine; parenteral

2.5

52.6

380

1003

A07AA02

ATC

nystatin; oral

1.5

52.6

2087

9373

E000002, ,

ATC

1.3

52.4

4152

20879

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.5

52.4

2112

9516

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

52.2

2573

12023

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

52.1

1521

6406

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.3

52.1

441

1252

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

51.9

4049

20316

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

51.8

1661

7143

TQW40, ,

SPAT

1.4

51.7

2765

13100

J98.6

ICD-10 Finland

Disorders of diaphragm

3.6

51.7

194

349

S20

ICPC

Corn/callosity

1.9

51.7

730

2520

SDA05

NOMESCO Finland

Very demanding periodontal treatment

1.4

51.7

2580

12084

S94

ICPC

Ingrowing nail

2.0

51.6

611

1984

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.8

51.6

908

3357

K02

ICPC

Pressure/tightness of heart

1.8

51.6

817

2926

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.0

51.5

612

1990

N19

ICD-10 Finland

Unspecified kidney failure

1.7

51.5

1142

4501

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

51.4

1496

6298

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.5

51.4

1967

8773

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.7

51.4

1123

4409

H93.1

ICD-10 Finland

Tinnitus

1.4

51.3

2663

12554

A28

ICPC

Limited function/disability NOS

1.3

51.3

5817

30604

S83.2

ICD-10 Finland

Tear of meniscus, current

1.4

51.2

2784

13228

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

51.2

1397

5795

L84

ICPC

Back syndrome without radiat pain

1.5

51.1

1707

7405

XF640, ,

NOMESCO Finland

1.7

51.0

924

3445

A10BD03

ATC

metformin and rosiglitazone; systemic

2.1

50.8

505

1534

A01AB09

ATC

miconazole; local oral

1.4

50.4

3115

15104

-34

ICPC

Blood test

1.7

50.3

1000

3827

K42

ICD-10 Finland

Umbilical hernia

2.3

50.3

412

1153

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.9

50.3

750

2635

F41.00

ICD-10 Finland

Moderate panic disorder

2.1

50.3

553

1747

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

50.2

1832

8092

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

50.2

1192

4781

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

50.1

1278

5217

NBG10

NOMESCO Finland

Acromioplastia

1.7

50.0

904

3368

OAA11, ,

SPAT

0.3

49.9

165

3303

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

2.5

49.9

348

904

R30.1

ICD-10 Finland

Vesical tenesmus

1.8

49.8

751

2648

H25.0

ICD-10 Finland

Senile incipient cataract

1.4

49.8

2205

10109

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

49.7

4210

21356

EC1VA, ,

NOMESCO Finland

1.6

49.7

1172

4692

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

49.6

1226

4967

C09BA03

ATC

lisinopril and diuretics; oral

1.8

49.5

770

2742

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

49.5

1373

5717

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.7

49.5

1002

3855

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

49.4

1863

8283

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

49.4

838

3065

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.2

49.3

454

1337

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.4

49.3

382

1043

R39.1

ICD-10 Finland

Other difficulties with micturition

1.6

49.2

1129

4488

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

1.7

49.2

998

3841

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.7

49.2

912

3423

TQW80

NOMESCO Finland

Local dermatologic skincare

1.7

48.9

984

3778

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

48.6

4546

23354

L89

ICPC

Osteoarthrosis of hip

1.6

48.6

1239

5057

K77

ICPC

Heart failure

1.9

48.6

648

2195

A10BG02

ATC

rosiglitazone; oral

2.2

48.4

469

1410

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

2.4

48.4

354

941

R81

ICPC

Pneumonia

1.6

48.3

1261

5177

R75

ICPC

Sinusitis acute/chronic

1.5

48.3

1709

7504

EB1TW

NOMESCO Finland

3D modelling of dentition

6.6

48.2

WX204

NOMESCO Finland

Axillary plexus blockaced

1.6

48.1

1200

4871

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.4

48.1

2091

9553

W19

ICD-10 Finland

Unspecified fall

1.3

48.1

3638

18169

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

1.8

48.1

742

2636

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

48.0

7131

38614

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

47.8

1089

4322

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.8

47.8

765

2749

J96.0

ICD-10 Finland

Acute respiratory failure

2.2

47.8

435

1275

H53.2

ICD-10 Finland

Diplopia

1.6

47.7

1113

4444

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.8

47.7

748

2671

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

47.6

2631

12529

K04.09

ICD-10 Finland

Pulpit UNS

1.5

47.5

1705

7507

RK120, ,

NOMESCO Finland

4.1

47.5

151

240

N18.8

ICD-10 Finland

Other chronic renal failure

1.8

47.5

830

3063

K28

ICPC

Limited function/disability (K)

1.8

47.4

711

2504

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.1

47.3

494

1531

L04AX03

ATC

methotrexate; systemic

1.3

47.2

3778

19015

-1, ,

SPAT

1.6

47.1

1325

5536

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.4

46.7

2280

10634

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

2.2

46.7

418

1217

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.5

46.6

1386

5863

R25.1

ICD-10 Finland

Tremor, unspecified

1.6

46.6

1071

4261

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.2

46.5

452

1361

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.7

46.5

915

3493

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

2.7

46.4

272

646

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.5

46.4

1356

5713

E000006, ,

ATC

1.4

46.4

2450

11580

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

2.8

46.4

265

621

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.5

46.3

1699

7514

K92.1

ICD-10 Finland

Melaena

1.5

46.2

1809

8102

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

46.2

2043

9362

H92.0

ICD-10 Finland

Otalgia

1.4

46.2

2184

10129

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

1.8

46.2

772

2811

DFF15

NOMESCO Finland

Speech audiometry

1.5

46.2

1651

7264

E000003, ,

ATC

1.5

46.1

1561

6790

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

46.1

2354

11063

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.9

46.1

612

2070

WX111

NOMESCO Finland

Local infiltration anesthesia

1.6

46.0

1207

4960

OAB91, ,

SPAT

1.4

46.0

2296

10750

K59.0

ICD-10 Finland

Constipation

1.4

46.0

1911

8658

N41.1

ICD-10 Finland

Chronic prostatitis

1.7

46.0

870

3285

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

45.9

1302

5448

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

1.7

45.7

936

3613

R15

ICD-10 Finland

Faecal incontinence

1.7

45.7

938

3623

B01AB04

ATC

dalteparin; parenteral

1.4

45.7

1889

8551

R51

NOMESCO Finland

Aids services

8.6

45.6

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.6

45.6

1144

4651

4211

FHL

Transeptal septal resection and reconstruction

2.3

45.5

367

1021

K02

ICD-10 Finland

Dental caries

1.4

45.5

2652

12740

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

2.8

45.4

252

581

TAB00

NOMESCO Finland

Lumbar puncture

1.5

45.4

1618

7113

K04.00

ICD-10 Finland

Hyperemia of pulp

1.5

45.4

1689

7490

C07FB02

ATC

metoprolol and felodipine; systemic

1.7

45.4

898

3434

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

45.3

4468

23100

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.7

45.2

822

3068

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

1.9

45.2

610

2074

B02AA02

ATC

tranexamic acid; systemic

1.2

45.1

5820

31037

NG1DA

NOMESCO Finland

X-ray of knees

1.9

45.0

639

2210

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.2

45.0

204

417

WX200

NOMESCO Finland

Interscalenous plexus blockade

1.8

44.9

777

2859

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.6

44.7

1092

4411

VALMI, ,

NOMESCO Finland

1.2

44.6

9839

55248

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.9

44.6

618

2121

C09BA04

ATC

perindopril and diuretics; systemic

1.9

44.6

609

2080

TMA00

NOMESCO Finland

Episiotomy

0.3

44.5

145

2924

WX892

NOMESCO Finland

Monitored bed care

1.4

44.5

2758

13374

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

44.4

5118

26948

A10BD15

ATC

metformin and dapagliflozin; oral

2.4

44.4

323

857

H70

ICPC

Otitis externa

1.8

44.3

767

2822

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.1

44.3

452

1388

K07.18

ICD-10 Finland

Another anomaly in the relationship between jaw and skull base

4.6

44.3

122

172

-42

ICPC

Electrical tracing

2.1

44.3

490

1553

K05.3

ICD-10 Finland

Chronic periodontitis

1.4

44.2

1868

8489

XJH00

NOMESCO Finland

Transanal ultrasonography

1.4

44.2

2002

9214

Z34

ICD-10 Finland

Supervision of normal pregnancy

0.4

44.2

247

3891

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.4

44.1

1866

8481

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

44.0

2743

13312

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.6

44.0

1055

4243

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.5

43.9

1306

5524

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.1

43.9

463

1440

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.5

43.9

1301

5499

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

2.6

43.9

283

707

H60.3

ICD-10 Finland

Other infective otitis externa

1.7

43.8

830

3135

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.8

43.8

735

2680

J32.4

ICD-10 Finland

Chronic pansinusitis

2.0

43.8

556

1852

L20

ICPC

Joint symptom/complaint NOS

1.5

43.8

1340

5705

QDB10, ,

SPAT

1.9

43.5

604

2074

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

43.5

2433

11608

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.7

43.5

966

3810

SPAT1234

SPAT

Support of social functional capacity

1.5

43.4

1638

7286

N30.0

ICD-10 Finland

Acute cystitis

1.2

43.4

5836

31253

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

1.7

43.3

839

3189

L29.9

ICD-10 Finland

Pruritus, unspecified

1.7

43.3

921

3591

R06

ICD-10 Finland

Abnormalities of breathing

2.2

43.3

392

1147

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.6

43.2

984

3906

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

1.8

43.2

735

2692

R06.4

ICD-10 Finland

Hyperventilation

1.9

43.1

563

1894

C07AB05

ATC

betaxolol; oral

1.7

43.0

819

3098

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.4

43.0

2651

12843

UJF92

NOMESCO Finland

Capsular endoscopy

1.8

43.0

767

2848

OAB74, ,

SPAT

2.5

43.0

293

753

-54

ICPC

Repair/fix-suture/cast/prosth device

1.7

43.0

816

3085

A10AB04

ATC

insulin lispro; parenteral

1.6

42.9

1152

4762

K63.5

ICD-10 Finland

Polyp of colon

1.8

42.8

719

2622

S09

ICPC

Infected finger/toe

1.6

42.8

1078

4387

OAB44, ,

SPAT

1.4

42.7

2540

12236

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

3.4

42.7

174

332

N20.9

ICD-10 Finland

Urinary calculus, unspecified

1.7

42.7

930

3649

SPAT1131

SPAT

Colonoscopy

1.6

42.7

1087

4436

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.0

42.7

489

1570

C08CA05

ATC

nifedipine; systemic

1.4

42.6

2070

9645

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.7

42.6

778

2909

SPAT1284

SPAT

Extensive health certificate

1.6

42.5

956

3782

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

1.8

42.5

669

2392

N05AB03

ATC

perphenazine; systemic, rectal

1.5

42.5

1241

5229

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

3.3

42.4

179

350

R07.2

ICD-10 Finland

Precordial pain

1.8

42.3

747

2766

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.8

42.2

687

2482

M01AB51

ATC

indometacin, combinations; oral, rectal

1.7

42.2

806

3052

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

42.2

2980

14733

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

42.1

4184

21641

130

Kela drug reimbursment

Malignant tumour

0.7

42.0

1899

16967

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

41.9

2119

9942

N05AF01

ATC

flupentixol; systemic

1.9

41.8

547

1841

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.4

41.8

2240

10612

L09

ICPC

Arm symptom/complaint

1.4

41.8

1691

7623

G54.0

ICD-10 Finland

Brachial plexus disorders

1.6

41.7

930

3672

C07AB03

ATC

atenolol; systemic

1.4

41.6

1815

8295

Z08

ICPC

Social welfare problem

2.0

41.5

479

1542

C09BX01

ATC

perindopril, amlodipine and indapamide; systemic

2.7

41.5

247

592

OAA81, ,

SPAT

1.6

41.5

1108

4574

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

41.4

1598

7137

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

1.8

41.4

667

2403

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.7

41.3

897

3517

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

41.3

4261

22137

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013290) Carbon dioxide [Partial pressure] in Blood

2184

5605

2.58

320.74

4.3

3.8

5.10

4.96

kpa

14.23

2141

5468

(3012501) Base excess in Blood by calculation

2183

5604

2.58

320.41

4.3

3.8

2.49

2.50

mmol/l

0.03

1559

3757

(3027315) Oxygen [Partial pressure] in Blood

2190

5646

2.57

318.70

4.4

3.8

8.71

8.62

kpa

1.52

2147

5508

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6794

26893

1.72

317.58

3.6

3.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

13282

61987

1.51

314.45

1.3

1.25

1.81

u/ml

8.77

3763

16793

(3010421) pH of Blood

2411

6557

2.44

314.32

4.3

3.7

7.42

0.24

2274

5905

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5728

21678

1.79

312.04

4.0

3.8

1.22

1.23

mmol/l

6.44

4963

19050

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

20077

100133

1.47

307.65

3.5

3.2

0.03

0.36

e6/l

—

(3010813) Leukocytes [#/volume] in Blood

54040

331821

3.12

307.65

25.4

19.4

6.96

6.63

e9/l

177.45

53040

322199

(3022096) Basophils/100 leukocytes in Blood

26249

130751

1.57

307.65

6.2

0.68

0.12

24548

122410

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

52124

298455

3.17

307.65

6.0

4.6

2.73

2.82

mmol/l

88.89

48488

277530

(3021901) Oxygen saturation in Capillary blood

1861

4301

2.86

307.65

2.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

15167

71558

1.51

307.65

4.2

4.1

21.96

21.94

0.05

6774

33510

(3019309) Folate [Moles/volume] in Red Blood Cells

11747

48074

1.74

307.65

1.9

1.7

1174.05

1161.72

nmol/l

0.70

8943

36694

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

28642

138478

1.70

307.65

7.2

6.7

1.21

mmol/l

0.06

23724

118442

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2612

5799

3.01

307.65

3.1

3.0

25.22

24.48

mmol/l

14.48

2572

5656

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10839

46345

1.64

307.65

1.3

8.84

12.34

u/ml

5.24

4235

18261

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8694

35419

1.70

307.65

6.0

1.05

1.03

mmol/l

10.44

8128

33131

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

5732

6960

5.83

307.65

3.1

4.6

24.93

24.76

mmol/l

3.25

5383

6379

(3020564) Creatinine [Moles/volume] in Serum or Plasma

53181

315375

3.23

307.65

19.7

15.3

80.38

76.69

umol/l

90.60

53168

315243

(3006315) Basophils [#/volume] in Blood

28837

144281

1.61

307.65

5.9

6.0

0.04

e9/l

20.45

25382

125255

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7976

28883

1.92

307.65

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

14262

61033

1.69

307.65

1.6

1.5

20.22

20.32

nmol/l

0.34

12205

52669

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

53363

316288

3.44

307.65

12.3

9.9

30.68

26.45

u/l

279.22

51714

306167

(3041096) Erythrocytes [Presence] in Urine by Automated

15618

74895

1.49

307.65

3.6

3.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

49344

277816

2.36

307.65

15.5

12.3

81.62

82.67

ml/min/173m2

23.21

42747

228697

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

51223

291398

2.80

307.65

5.4

4.1

1.33

1.48

mmol/l

307.65

47553

271256

(3028626) Oxygen [Partial pressure] in Capillary blood

2203

5264

2.78

307.65

3.3

3.1

8.36

8.17

kpa

5.28

2170

5135

(3012095) Magnesium [Moles/volume] in Serum or Plasma

10341

45027

1.60

307.65

3.2

3.5

0.82

mmol/l

10.37

9680

42257

(3012516) Albumin [Mass/volume] in Urine

21074

77629

2.22

307.65

3.5

3.2

320.71

447.41

mg/l

3.78

13943

48811

(3002030) Lymphocytes/100 leukocytes in Blood

27870

139632

1.59

307.65

6.3

6.2

27.94

28.02

0.54

26252

131597

(3000492) Spirometry study

7366

28321

1.79

307.65

1.5

1.4

—

(3007461) Platelets [#/volume] in Blood

54020

331455

3.12

307.65

25.4

19.4

252.31

252.18

e9/l

0.17

53161

322793

(3013115) Eosinophils [#/volume] in Blood

29890

148823

1.65

307.65

6.1

6.3

0.21

0.19

e9/l

44.59

26664

130938

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

49752

265162

3.08

307.65

5.7

4.5

2.01

2.13

mu/l

0.82

46232

244308

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9613

39606

1.69

307.65

2.7

2.5

2.41

2.32

g/l

47.33

8858

36755

(3026361) Erythrocytes [#/volume] in Blood

54036

331808

3.11

307.65

25.3

19.4

4.60

4.51

e12/l

284.37

53028

322214

(1002224) Polysomnography panel

7632

7855

7.13

307.65

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

24737

110810

1.80

307.65

2.1

1.9

99.05

95.62

pmol/l

21.45

13483

57706

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

51506

293508

2.91

307.65

5.5

4.1

4.57

4.73

mmol/l

237.17

48143

274271

(3023103) Potassium [Moles/volume] in Serum or Plasma

52744

301374

3.72

307.65

19.7

15.1

3.98

3.97

mmol/l

24.52

51764

293413

(40768797) Stomach Pathology biopsy report

9786

38134

1.80

307.65

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

27585

128312

1.78

307.65

16.4

13.4

1.25

1.24

inr

0.09

9251

36325

(3035350) Ketones [Presence] in Urine by Test strip

26695

138773

1.47

307.65

3.9

3.5

0.00

estimate

0.77

6469

26234

(3018010) Neutrophils/100 leukocytes in Blood

27448

137601

1.58

307.65

6.0

57.36

57.12

2.78

25813

129606

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

30084

148115

1.69

307.65

5.5

6.4

10.88

11.43

umol/l

12.70

28444

140871

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

19860

89122

1.69

307.65

4.9

4.7

2.74

3.17

ug/l

0.65

17769

80425

(3006504) Eosinophils/100 leukocytes in Blood

27132

134922

1.59

307.65

6.2

2.96

2.85

12.57

25472

126656

(3019550) Sodium [Moles/volume] in Serum or Plasma

52626

300363

3.63

307.65

19.6

15.0

139.84

139.67

mmol/l

58.05

51701

292987

(3019225) pH of Specimen

6795

25936

1.79

307.65

4.4

4.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

19626

88954

1.66

307.65

2.7

2.6

58.21

62.80

u/l

1.31

17983

82467

(3009261) Glucose [Presence] in Urine by Test strip

26873

140407

1.46

307.65

3.9

3.5

0.01

0.00

estimate

2.30

5862

24337

(3013650) Neutrophils [#/volume] in Blood by Automated count

31645

167249

1.52

307.65

8.2

9.5

4.26

4.06

e9/l

43.24

27975

146400

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

8857

32306

1.92

307.65

5.1

4.2

30.30

32.61

75.69

7029

21884

(3013707) Erythrocyte sedimentation rate by Westergren method

41741

213139

2.08

307.65

4.8

3.9

12.69

11.63

mm/h

41.33

38849

198183

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

51186

294183

2.64

307.65

17.0

13.3

20.30

24.03

mg/l

127.63

43947

229189

(3019069) Monocytes/100 leukocytes in Blood

27280

135687

1.59

307.65

6.5

8.43

8.60

15.14

25653

127575

(3026493) Urate [Moles/volume] in Serum or Plasma

18355

73309

1.93

307.65

2.8

2.5

3587.82

4223.38

umol/l

1.38

16011

64906

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

18663

83878

1.66

307.65

2.3

2.1

180.44

217.02

u/l

7.71

17469

78895

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9017

36981

1.69

307.65

2.8

2.6

22.40

23.09

4.68

7755

31662

(3022948) Iron [Moles/volume] in Serum or Plasma

10383

42921

1.70

307.65

2.7

2.5

13.38

13.72

umol/l

0.32

9641

40187

(3009343) pH of Capillary blood

8041

12339

4.76

307.65

3.1

3.9

7.41

7.42

5.29

843

1877

(3009508) Creatinine [Moles/volume] in Urine

22178

83869

2.19

307.65

3.5

3.2

8.23

7.58

mmol/l

69.08

18323

71624

(40761536) Microorganisms panel - Urine sediment

6146

22218

1.89

307.65

4.3

3.8

—

(3021589) Normoblasts [#/volume] in Blood

24641

127434

1.45

307.65

11.0

9.3

0.00

e9/l

2.34

20582

104450

(3015377) Calcium [Moles/volume] in Serum or Plasma

19518

93384

1.54

307.65

2.9

3.5

2.35

mmol/l

1.16

17242

82711

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

19327

71886

2.14

307.65

3.3

2.8

1043.13

1378.82

ng/l

21.32

15917

61751

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

50030

281202

2.55

307.65

4.9

3.7

1.52

1.27

mmol/l

307.65

46112

260045

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

15101

66779

1.64

307.65

2.4

2.2

3.07

2.90

mg/l

12.41

13019

57180

(3001122) Ferritin [Mass/volume] in Serum or Plasma

25673

120045

1.71

307.65

3.2

2.8

133.37

131.07

ug/l

0.61

23632

111939

(3021601) Nitrite [Presence] in Urine by Test strip

26661

138834

1.47

307.65

5.2

4.7

0.00

estimate

0.00

6249

24893

(1616796) Gas panel - Central venous blood

2240

5430

2.74

307.65

3.7

3.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

34197

183838

1.53

307.65

4.9

4.1

938.15

1314.53

e6/l

0.81

542

2451

(3009542) Hematocrit [Volume Fraction] of Blood

54002

331123

3.12

307.65

25.4

19.5

41.38

40.57

6.08

51494

310638

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

21076

107229

1.44

307.65

4.1

3.6

—

(40761511) CBC panel - Blood by Automated count

51881

307874

2.41

307.65

16.5

12.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

43631

219244

2.35

307.65

4.6

3.8

14.71

14.74

pmol/l

1.59

39987

200824

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6201

20732

2.05

307.65

2.7

2.0

11.93

13.12

nmol/l

26.09

5521

18718

(3024731) MCV [Entitic volume]

54035

331775

3.11

307.65

25.3

19.4

90.83

90.92

4.49

53517

327298

(3020682) Albumin/Creatinine [Ratio] in Urine

22044

81720

2.24

307.65

4.2

3.8

9.21

8.95

mg/mmol

0.28

14188

51259

(3044889) 12 lead EKG panel

38183

202374

1.71

307.65

4.3

3.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

24671

115145

1.70

307.65

2.6

2.2

3759.38

77.19

nmol/l

0.50

22259

104331

(3023368) Bacteria identified in Blood by Culture

15563

74193

1.50

307.65

4.5

4.3

—

(3013512) EKG study

19252

76675

1.96

307.65

4.4

3.6

—

(1761868) Lipid panel - Serum or Plasma

21438

107825

1.47

307.65

3.3

2.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

7750

11919

4.73

307.65

3.1

3.9

1.58

1.79

mmol/l

4.08

5948

8648

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

50958

282026

3.09

307.65

5.8

4.2

6.17

5.87

mmol/l

307.65

46794

259698

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14120

55980

1.85

307.65

1.8

1.6

36036530.19

37237181.70

pmol/l

0.07

11630

46865

(3019198) Lymphocytes [#/volume] in Blood

29450

148319

1.61

307.65

6.0

2.01

1.91

e9/l

11.35

26493

131549

(3000963) Hemoglobin [Mass/volume] in Blood

54038

331912

3.10

307.65

25.5

19.5

138.27

136.13

g/l

207.86

53529

327462

(4200892) Spirometry reversibility

5886

19124

2.11

307.65

1.5

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2233

5398

2.75

307.65

2.2

1.8

190.83

207.31

pmol/l

10.18

2114

5132

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

23814

103067

1.87

307.65

4.1

3.3

52.59

64.76

ng/l

0.75

16417

67374

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

50551

266464

3.58

307.65

7.6

5.2

41.30

39.23

mmol/mol

307.65

47409

247677

(3024561) Albumin [Mass/volume] in Serum or Plasma

25356

120967

1.66

307.65

4.7

4.9

35.98

35.61

g/l

22.91

23526

112692

(40760892) CBC W Ordered Manual Differential panel - Blood

27799

135159

1.66

307.65

6.6

6.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

26241

125219

1.68

307.65

6.4

6.0

1.21

mmol/l

0.81

23887

114772

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

8113

12541

4.73

307.65

3.1

3.9

5.24

5.09

kpa

36.53

7719

11866

(3035941) MCH [Entitic mass]

54029

331734

3.11

307.65

25.2

19.3

30.23

30.32

27.69

53512

327267

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11335

49403

1.61

307.65

1.3

34.20

35.76

iu/ml

0.17

3415

16290

(3001604) Monocytes [#/volume] in Blood

28778

143957

1.61

307.65

5.9

6.0

0.60

0.58

e9/l

32.96

25342

125089

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2866

7809

2.45

307.65

2.0

1.7

34.09

42.55

nmol/l

70.01

2782

7626

(3013826) Glucose [Moles/volume] in Serum or Plasma

34152

163667

1.91

307.65

5.2

4.6

6.86

6.68

mmol/l

39.41

32301

153386

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16633

74151

1.65

307.65

1.8

1.6

1.59

1.35

mmol/l

142.26

13292

63325

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

38362

199091

1.80

307.65

3.7

3.0

54.24

47.42

u/l

39.19

35772

187132

(3037467) Urinalysis macro (dipstick) panel - Urine

37059

194574

1.70

307.65

4.8

4.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20153

95483

1.57

307.65

3.1

3.3

32.83

34.05

u/l

1.45

18918

90826

(3022313) Gas panel - Capillary blood

6491

8142

5.71

307.65

3.0

4.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7378

24005

2.14

307.65

2.2

2.3

340.62

380.53

nmol/l

49.85

6775

22217

(3005322) IgE [Units/volume] in Serum or Plasma

5070

16920

2.03

307.65

1.4

1.3

226.80

245.10

u/ml

0.51

4744

15636

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14747

60887

1.77

307.65

1.9

1.7

0.94

1.23

mg/l

26.99

11207

46552

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

42668

222183

2.05

307.65

7.7

7.6

77.76

77.90

u/l

0.25

40306

210227

(3037522) Nuclear Ab [Titer] in Serum

9301

39253

1.64

307.65

1.4

1.3

501.29

545.96

titre

1.38

1851

8017

(3029937) Albumin [Presence] in Urine by Test strip

15220

73403

1.47

304.79

4.3

3.9

0.00

estimate

0.92

5977

23921

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

11190

51277

1.52

284.15

3.1

2.9

0.68

0.78

ug/l

19.78

7137

32934

(3018418) pH of Serum or Plasma

16700

82848

1.44

283.83

4.3

4.2

7.40

2.29

4131

14881

(3015736) pH of Urine

21660

112575

1.40

283.13

3.5

3.2

5.75

5.85

5.92

1674

9136

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8433

36370

1.59

279.77

1.9

1.8

1.45

0.03

7307

32294

(3000494) Fungus identified in Specimen by Culture

7734

32755

1.61

276.24

1.5

1.4

—

(3022145) Colonoscopy Study observation

7578

31963

1.62

275.10

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9667

43357

1.54

269.09

2.0

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

12280

58046

1.47

265.26

2.8

2.6

5.11

5.41

e6/l

1.79

11002

52088

(3007164) IgA [Mass/volume] in Serum or Plasma

11584

54225

1.48

262.25

1.5

1.4

2.53

2.40

g/l

8.34

7267

33410

(3007853) Bacteria identified in Skin by Aerobe culture

7635

32746

1.59

257.14

1.9

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

1957

5330

2.43

253.51

2.8

2.4

17.12

16.23

13.99

1118

2645

(3002582) Erythrocytes [#/volume] in Urine

16773

84605

1.41

252.66

3.5

3.2

63.83

92.18

e6/l

2.23

13173

64588

(3026782) Osmolality of Urine

11608

54776

1.47

250.63

3.1

2.8

550.44

540.70

mosm/kgh2o

3.98

9981

47120

(3018095) Leukocytes [#/volume] in Urine

19140

98861

1.39

250.05

3.9

3.6

78.02

94.84

e6/l

2.00

14097

69711

(3002179) Metamyelocytes/100 leukocytes in Blood

5371

21305

1.70

244.78

3.7

4.1

0.63

0.70

1.04

1695

6900

(3021440) Promyelocytes/100 leukocytes in Blood

5549

22291

1.68

241.12

3.9

4.3

0.09

0.12

2.04

1668

6871

(3017181) Myelocytes/100 leukocytes in Blood

5765

23513

1.65

236.14

3.9

4.2

0.87

0.99

2.56

1875

8051

(3025159) Blasts/100 leukocytes in Blood

5296

21125

1.69

235.95

4.0

4.3

0.26

0.35

1434

5782

(3048689) Calprotectin [Mass/mass] in Stool

7831

34579

1.54

229.91

2.3

2.4

130.16

137.55

ug/g

1.01

6129

27594

(3019060) Gas panel - Arterial blood

4493

17372

1.73

223.38

4.7

5.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

33704

192310

1.34

218.96

3.0

2.9

—

(40768804) Tissue Pathology biopsy report

22082

118644

1.34

213.96

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

15263

77611

1.38

210.03

3.4

3.1

0.41

e6/l

0.01

11865

58686

(3009214) Lutropin [Units/volume] in Serum or Plasma

2300

7309

2.08

206.52

1.5

1.4

8.71

11.17

u/l

11.38

1867

5969

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

24385

133383

1.33

206.35

2.6

2.5

—

(3042936) Bacteria identified in Isolate by Culture

8576

39961

1.46

190.50

2.2

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3004

10782

1.85

190.13

2.1

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4134

16308

1.69

189.79

7.1

7.3

25.12

24.69

mmol/l

11.51

4089

16170

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1140

2734

2.73

189.77

1.2

27.22

29.78

nmol/l

—

(3003129) Base excess in Capillary blood by calculation

401

435

6.00

188.56

1.5

1.9

0.67

0.51

mmol/l

0.25

388

397

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4360

17482

1.67

188.25

3.2

3.4

4.48

4.47

pmol/l

0.18

3863

15649

(3002385) Erythrocyte distribution width [Ratio]

42933

256413

1.37

186.85

18.8

16.0

15.56

14.88

29.10

42248

251996

(36304419) Bacteria [Presence] in Urine

14772

75824

1.36

186.77

3.3

3.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

5065

21209

1.60

183.92

2.5

2.7

10.56

10.57

g/l

0.02

4554

19515

(4146454) Self-monitoring of blood glucose

1069

2531

2.77

182.20

2.7

2.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4799

19958

1.61

178.97

4.0

3.9

95.71

90.31

ng/l

3.00

4091

17422

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2745

9844

1.85

173.81

1.9

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3149

11794

1.77

173.06

2.2

2.0

39.47

39.53

u/l

0.06

2798

10519

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1859

5832

2.10

172.12

2.3

2.1

134.81

129.42

g/l

13.81

1385

4193

(3003396) Base excess in Arterial blood by calculation

6872

31281

1.48

169.97

7.5

7.4

1.38

0.98

mmol/l

13.67

5632

24959

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1934

6204

2.05

168.88

2.3

155.49

99.66

ug/min

3.56

1148

3694

(3004588) Protein electrophoresis panel - Serum or Plasma

4321

17767

1.62

168.22

2.1

2.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6859

31294

1.48

167.49

7.5

5.25

5.06

kpa

41.90

6571

29870

(3027801) Oxygen [Partial pressure] in Arterial blood

6853

31278

1.48

167.00

7.5

11.24

12.76

kpa

122.39

6557

29850

(3028026) IgM [Mass/volume] in Serum or Plasma

4038

16416

1.64

164.29

1.8

1.9

1.17

1.35

g/l

7.07

3651

15044

(3026008) Bacteria identified in Urine by Culture

15420

80902

1.32

163.35

3.3

3.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

5532

24328

1.52

160.78

8.1

7.5

10.26

9.56

mmol/l

9.84

5247

23176

(3016244) Insulin [Units/volume] in Serum or Plasma

681

1356

3.28

155.24

3.6

3.2

37.36

24.57

mu/l

8.60

648

1266

(3028271) Lactate [Moles/volume] in Capillary blood

1382

4042

2.24

151.88

2.1

1.8

1.73

1.75

mmol/l

0.29

1362

3934

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1573

4853

2.13

151.78

3.1

3.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5037

21991

1.53

150.78

3.1

2.8

154.56

201.01

ng/l

13.65

4519

20036

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

832

1906

2.85

150.44

2.0

18.33

17.62

nmol/l

1.39

789

1794

(3016502) Oxygen saturation in Arterial blood

6145

28019

1.47

149.14

7.8

7.9

94.97

95.87

22.33

5958

26952

(3020630) Protein [Mass/volume] in Serum or Plasma

5015

21931

1.53

148.88

2.2

2.6

67.12

66.40

g/l

9.52

4560

20067

(3017732) Neutrophils [#/volume] in Blood

4569

19611

1.55

147.49

2.8

4.82

4.98

e9/l

0.33

3685

15962

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10049

50193

1.36

144.92

2.7

3.1

2.45

mmol/l

2.66

8759

44043

(3044640) Blood type and Crossmatch panel - Blood

16663

89483

1.29

144.53

2.4

—

(3023419) Bacteria identified in Sputum by Culture

1281

3746

2.24

140.77

2.6

2.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3045

12033

1.67

137.30

1.5

13.33

14.91

u/ml

0.24

342

(3011985) Renin [Units/volume] in Plasma

1229

3571

2.25

137.09

1.5

70.00

63.89

mu/l

0.42

1087

3200

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1606

5206

2.03

136.04

1.2

91.52

150.38

titre

0.86

106

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10673

54356

1.34

133.90

4.2

3.5

464.04

524.31

ng/l

0.25

7886

41184

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2478

9347

1.75

132.03

1.7

1.6

262.60

286.92

titre

0.14

391

(3022806) Fractional oxyhemoglobin in Capillary blood

1135

3257

2.28

130.29

2.0

1.8

89.76

89.73

0.04

1122

3201

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4307

18771

1.53

128.91

1.2

127.36

145.66

iu/ml

2.25

1571

7173

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4463

19686

1.51

126.14

2.4

2.3

20.77

23.87

au/ml

1.18

284

1631

(4094501) Cardiovascular stress test using bicycle ergometer

2067

7503

1.81

125.12

1.1

—

(3025941) Bacteria identified in Stool by Culture

3814

16329

1.55

123.52

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

6339

30101

1.41

121.79

2.6

2.5

1.85

1.75

12.07

5571

26773

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4107

17946

1.52

121.10

1.3

48.27

53.63

au/ml

0.70

193

962

(3013139) Helicobacter pylori Ag [Presence] in Stool

4278

18864

1.51

120.84

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2290

8665

1.74

120.49

1.8

1.7

296.72

310.53

mu/l

0.76

2040

7891

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1125

3327

2.21

120.31

1.3

317.65

354.87

pmol/l

0.55

992

2878

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12811

67951

1.29

116.79

2.4

2.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2037

7541

1.78

115.43

2.3

2.0

10.54

11.07

mg/l

1.89

1902

7044

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5624

26389

1.42

115.09

2.1

2.3

0.22

0.21

g/l

12.74

5234

24572

(3023520) Reticulocytes [#/volume] in Blood

4874

22275

1.46

114.93

2.7

2.6

74.44

68.83

e9/l

20.52

3802

16668

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1204

3741

2.11

113.92

1.3

1.76

1.26

nmol/l

0.24

1162

3604

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1196

3737

2.09

111.54

1.3

0.28

0.23

nmol/l

0.24

263

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2765

11233

1.62

111.38

1.3

1.2

0.52

0.91

u/ml

1.62

235

999

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4943

22901

1.44

108.03

2.5

2.2

6.33

7.73

ug/l

5.06

4270

20126

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3349

14405

1.54

105.62

9.0

9.7

24.71

24.23

mmol/l

15.22

3232

13961

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

9871

51216

1.30

104.68

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1089

3388

2.10

102.68

1.3

—

(3012544) pH of Venous blood

5451

25989

1.40

100.94

4.5

3.9

7.37

7.38

1.23

171

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1477

5175

1.87

99.75

1.3

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

525

8471

0.40

99.43

1.4

1.5

—

(3002032) Base excess in Venous blood by calculation

5256

25011

1.40

98.27

4.5

3.9

2.12

1.81

mmol/l

7.91

4615

21280

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1006

3116

2.11

95.93

2.1

2.0

24.86

27.31

mg/l

0.68

297

810

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5247

25099

1.39

94.91

4.5

3.9

5.95

5.80

kpa

19.33

5112

24366

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

702

1874

2.44

94.52

1.3

0.71

1.75

u/ml

3.96

367

1066

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4312

19967

1.43

93.82

1.6

—

(3042631) Mycobacterium sp identified in Specimen

1082

3482

2.03

93.32

2.7

2.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2253

9105

1.63

92.33

2.5

2.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1205

4067

1.94

90.96

1.3

27.93

35.79

u/l

1.53

1042

3561

(3037121) Protein [Mass/volume] in Urine

2257

9174

1.62

90.35

2.9

3.2

0.34

0.31

g/l

0.61

928

4206

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2469

10262

1.58

90.12

1.9

1.6

5.10

3.54

mg/l

5.98

2153

7223

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

906

2768

2.14

89.46

1.7

1.6

—

(3045424) Erythrocytes [Presence] in Urine

1286

4482

1.88

88.23

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

13538

74295

1.24

87.28

3.9

4.0

91.47

90.88

1.72

13142

72493

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5386

26227

1.36

86.85

8.6

8.2

126.33

121.03

g/l

59.76

5268

25492

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2157

8760

1.62

86.59

1.6

1.7

1.26

1.16

g/l

45.35

2051

8329

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1483

5437

1.79

86.58

1.9

2.1

1.03

0.80

nmol/l

23.01

1227

4581

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6084

30201

1.34

86.56

1.8

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2100

8498

1.62

85.51

1.6

1.7

0.25

0.23

g/l

17.46

1995

8043

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6596

33209

1.32

85.06

2.4

2.8

7.31

8.72

umol/l

7.12

5609

28988

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6823

34528

1.32

84.85

7.3

6.7

—

(3012565) Volume of 24 hour Urine

520

1266

2.67

84.23

1.9

2.3

2025.24

1980.53

0.38

460

1134

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2136

8762

1.60

82.25

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3435

15631

1.45

81.60

1.7

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6327

31871

1.32

80.97

3.7

4.4

236.63

244.95

u/l

5.07

5942

30229

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

477

1142

2.72

79.77

1.1

6.79

7.74

u/ml

0.25

187

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3213

14535

1.46

78.62

2.5

2.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1906

7708

1.62

77.72

1.5

11.30

15.21

iu/ml

0.74

179

(3027923) C peptide [Moles/volume] in Serum or Plasma

533

1370

2.53

77.68

1.6

1.5

1.45

1.16

nmol/l

5.73

396

1105

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1831

7338

1.64

77.40

1.4

—

(40768443) Skin Pathology biopsy report

2804

12392

1.49

77.15

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6031

30370

1.32

77.07

1.9

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

316

5707

0.35

77.03

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2463

10598

1.53

76.93

2.1

2.0

1.84

2.29

ug/l

0.99

2151

9422

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

922

3013

2.00

76.28

1.1

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

368

780

3.07

76.19

2.3

0.99

1.13

ug/l

0.48

332

746

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3662

17101

1.41

75.32

7.7

7.2

25.06

24.52

mmol/l

14.55

3524

16232

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3145

14307

1.45

74.63

1.1

1.0

—

(3034770) Mitochondria Ab [Titer] in Serum

1949

8006

1.60

74.53

1.2

924.38

938.31

titre

0.04

242

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8223

43323

1.27

74.03

2.1

30.13

29.74

6.22

7969

42063

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

748

2284

2.13

74.01

1.4

1.3

198.78

184.46

pmol/l

0.16

748

2284

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1960

8085

1.59

73.64

1.5

1.4

286.50

269.51

ug/g

2.92

1091

4757

(3020891) Body temperature

2454

10652

1.51

73.54

5.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3166

14477

1.44

73.05

2.9

2.7

0.25

0.28

e6/l

0.59

3093

14068

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1618

6375

1.66

73.03

1.7

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

987

3359

1.92

72.73

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

254

4955

0.33

72.73

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

228

4692

0.31

72.60

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

228

4688

0.31

72.48

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

225

4657

0.31

72.46

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

229

4675

0.31

71.79

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1821

7438

1.60

71.25

3.0

3.4

1.64

1.50

mg/l

8.34

1658

6879

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1970

8207

1.57

70.95

1.8

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2834

12781

1.46

70.26

3.9

3.4

25.54

25.21

mmol/l

5.59

2757

12384

(3024354) Oxygen [Partial pressure] in Venous blood

4230

20468

1.37

70.17

3.8

3.2

4.73

4.62

kpa

2.74

4103

19783

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

458

1149

2.59

70.11

1.7

1.6

14.42

5.99

nmol/l

0.32

375

973

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1229

4550

1.76

69.40

1.8

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

970

3349

1.89

68.49

1.5

—

(36660697) Celiac disease serology panel - Serum

4573

22478

1.34

68.46

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

854

2835

1.96

67.64

2.5

1.58

1.22

g/24h

2.27

451

1414

(3040151) Glucose [Moles/volume] in Capillary blood

860

2862

1.96

67.64

7.5

6.2

7.48

7.35

mmol/l

0.43

726

2332

(3021788) Differential panel - Synovial fluid

1314

4997

1.72

67.58

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1005

3535

1.86

67.03

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

983

3445

1.86

66.32

1.4

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

968

3378

1.87

66.17

1.6

56.27

57.42

0.34

591

2179

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1958

8276

1.55

66.16

2.8

3.5

38.36

43.97

mg/l

1.09

1452

6836

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1911

8033

1.56

66.16

2.7

3.5

2.69

4.71

ratio

0.82

136

661

(3014111) Lactate [Moles/volume] in Serum or Plasma

4927

24603

1.32

66.13

7.6

7.1

1.35

mmol/l

0.02

4802

24007

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1889

7921

1.56

66.10

1.3

33.10

37.04

u/ml

0.22

501

(3024522) Salmonella sp identified in Specimen by Organism specific culture

983

3450

1.86

66.02

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

975

3414

1.86

65.95

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

169

3873

0.28

65.92

1.4

—

(3049717) Cytology report of Urine Cyto stain

2338

10275

1.49

65.91

2.5

2.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

1935

8164

1.55

65.90

1.2

112.35

125.40

titre

0.28

183

731

(3034860) Kappa light chains.free [Mass/volume] in Serum

1959

8291

1.55

65.81

2.8

3.5

50.97

65.84

mg/l

0.90

1452

6839

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

973

3412

1.86

65.52

1.4

1.5

—

(3000991) Gas panel - Venous blood

4690

23287

1.33

65.44

9.1

8.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

970

3409

1.86

64.88

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

172

3864

0.29

64.70

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

183

3975

0.30

64.65

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2367

10494

1.48

63.88

1.6

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1536

6197

1.62

63.15

1.7

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1464

5851

1.64

62.49

1.2

6.85

15.42

u/ml

1.01

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1750

7329

1.56

61.54

1.3

6.60

7.94

u/ml

0.42

248

1171

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1157

4366

1.73

61.17

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

449

1207

2.42

59.76

1.2

175.35

154.24

mmol/24h

4.59

449

1207

(3020961) Endomysium IgA Ab [Titer] in Serum

2835

13185

1.41

59.27

1.1

266.30

210.39

titre

0.28

348

(3010838) Calcium [Moles/time] in 24 hour Urine

1289

5057

1.66

59.11

2.0

1.9

5.37

5.19

mmol/24h

1.01

1154

4497

(3045414) Leukocytes [Presence] in Urine

2683

12376

1.42

58.72

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1124

4256

1.72

58.71

1.1

45.18

3554.18

iu/ml

0.80

263

901

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1715

7234

1.55

58.43

1.3

7.31

5.86

u/ml

0.28

172

757

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

932

3348

1.82

58.19

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1474

6017

1.60

57.76

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

217

392

3.59

57.43

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

1504

6210

1.58

56.19

2.8

3.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

622

1971

2.05

56.05

1.6

1.5

—

(3019150) Specific gravity of Urine by Refractometry

10965

61111

1.20

55.90

4.2

3.9

1.02

kg/l

0.29

1640

9082

(3002256) Pathology report gross observation

7141

38140

1.24

55.45

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

946

3467

1.78

55.31

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

508

1495

2.21

55.15

1.1

4.72

5.66

nmol/l

0.19

100

282

(3004119) Hemoglobin [Mass/volume] in Venous blood

3379

16391

1.36

54.66

3.9

3.3

133.27

128.80

g/l

24.15

3303

16005

(3044927) Protein electrophoresis panel - Urine

719

2442

1.92

53.40

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1196

4731

1.65

53.15

1.5

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3576

17570

1.34

53.12

9.7

9.4

93.20

94.05

12.22

3558

17512

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2256

10271

1.44

52.94

1.9

2.3

7.42

7.35

g/l

1.18

2044

9290

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2551

11876

1.41

52.91

4.4

3.8

50.22

48.21

3.64

2519

11749

(3000475) Leukocytes [#/volume] in Synovial fluid

1584

6711

1.54

52.89

1.6

12847.95

13352.81

e6/l

0.14

1167

4879

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8275

45093

1.22

52.86

3.1

2.9

2.71

2.72

e6/l

0.03

4527

24246

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2253

10260

1.44

52.80

1.9

2.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

982

3691

1.73

52.68

1.5

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2249

10244

1.44

52.64

1.9

2.3

3.79

3.70

g/l

1.65

2039

9268

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1048

4017

1.70

52.42

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1165

4605

1.65

51.92

1.4

1.6

0.75

0.77

g/l

0.17

831

3509

(3024139) IgG subclass 3 [Mass/volume] in Serum

802

2852

1.83

51.76

1.3

1.4

0.39

0.41

g/l

0.24

528

2008

(3028192) IgG subclass 2 [Mass/volume] in Serum

802

2853

1.83

51.71

1.3

1.4

2.92

2.99

g/l

0.55

522

2002

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1834

8066

1.49

51.39

1.4

1.3

—

(4062490) Immunoglobulin typing, IgG

802

2859

1.83

51.37

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

950

3564

1.74

51.31

1.6

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

801

2857

1.83

51.21

1.3

1.4

6.62

6.83

g/l

0.85

519

2011

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

699

2388

1.91

51.04

1.3

1.70

1.35

nmol/l

10.23

644

2150

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1014

3882

1.70

50.95

1.1

1.46

1.51

g/l

4.47

918

3510

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

815

2928

1.81

50.91

1.7

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

2086

9439

1.45

50.55

4.4

4.3

1.34

1.38

mmol/l

1.04

2057

9267

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2129

9677

1.44

50.38

2.2

2.4

342.16

576.35

ug/l

4.09

1996

9078

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

8833

48658

1.21

50.23

2.9

2.7

0.95

1.17

e6/l

3.02

5094

27597

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2123

9676

1.44

49.50

2.0

2.4

2.86

2.94

g/l

3.19

1911

8701

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1416

5940

1.56

49.41

1.2

4.20

6.09

u/ml

0.36

105

453

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3529

17498

1.33

49.13

9.7

9.4

0.65

0.68

3.55

3511

17396

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1291

5308

1.59

49.11

1.1

1.06

2.03

u/ml

5.79

654

2562

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3534

17529

1.33

49.07

9.6

9.3

1.43

1.37

2.15

3511

17422

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

462

1374

2.19

48.97

1.6

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

507

1572

2.10

48.44

1.5

1.4

—

(3019977) pH of Arterial blood

462

1381

2.17

48.38

2.4

2.6

7.42

0.59

200

440

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

936

3558

1.71

48.27

1.3

7.58

7.26

mmol/l

2.38

826

3124

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

847

3129

1.76

48.26

1.1

1.39

2.17

iu/ml

1.01

(3028707) Methadone [Presence] in Urine by Screen method

1130

4524

1.63

47.93

2.7

3.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

462

1388

2.16

47.79

1.6

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1704

7497

1.49

47.64

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2593

12331

1.38

47.35

3.4

2.9

0.64

0.66

2.29

2584

12282

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2643

12608

1.37

47.35

3.4

2.9

1.35

1.28

2.16

2633

12540

(3038026) Centromere Ab [Units/volume] in Serum

641

2184

1.91

47.22

1.2

24.30

58.54

u/ml

2.25

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

403

1155

2.27

46.66

4.1

3.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3257

16111

1.33

46.01

1.5

—

(3017569) Oxygen content in Arterial blood

389

1107

2.28

45.79

2.3

2.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

624

2132

1.90

45.61

1.2

65.08

72.60

u/ml

0.20

102

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

624

2138

1.90

45.24

1.2

39.64

48.78

u/ml

0.45

161

(40758558) Short blood count panel - Blood

12915

74112

1.17

44.94

6.1

7.3

—

(44813793) Dust mix specific IgE antibody measurement

563

1871

1.96

44.63

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

600

2040

1.91

44.51

1.2

3.85

9.43

u/ml

1.49

144

(3017143) Hepatitis C virus Ab [Presence] in Serum

6240

33586

1.23

44.24

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1123

4586

1.60

43.97

1.1

0.89

1.05

u/ml

0.33

445

1883

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4508

23446

1.27

43.40

2.6

2.7

66.43

66.79

ml/min/173m2

0.21

1995

8960

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2064

9598

1.41

42.99

2.0

2.3

10.01

10.18

g/l

1.00

1839

8565

(3024666) Lithium [Moles/volume] in Serum or Plasma

494

1590

2.02

42.83

12.4

12.2

0.61

0.63

mmol/l

0.96

453

1459

(3003888) Timothy IgE Ab [Units/volume] in Serum

1163

4824

1.57

42.65

1.1

3.90

4.95

u/ml

1.65

566

2424

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2548

12288

1.36

42.56

1.7

1.60

1.53

g/l

2.85

2178

10507

(3000012) Reticulocyte production index

924

3637

1.65

41.92

2.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1082

4436

1.59

41.70

3.2

3.3

1.36

1.56

1.17

973

3950

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1076

4413

1.59

41.40

1.1

1.70

1.54

u/ml

0.21

528

2095

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2676

13089

1.34

40.72

5.0

4.3

24.39

24.08

mmol/l

5.71

2625

12785

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1889

8763

1.41

39.88

2.2

2.5

0.77

0.86

g/l

0.45

1624

7573

(3014271) Vancomycin [Susceptibility]

389

1175

2.15

39.81

3.1

2.8

—

(3020491) Glucose [Moles/volume] in Blood

561

1939

1.88

39.69

1.8

6.97

6.93

mmol/l

0.09

358

1429

(3003327) Ova and parasites identified in Stool by Light microscopy

2053

9672

1.39

39.60

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

697

2587

1.75

39.18

1.5

31.42

30.66

0.18

394

1658

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1572

7084

1.45

38.90

1.3

565.12

552.53

mg/l

0.12

1494

6752

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1364

5978

1.49

38.88

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

761

2911

1.70

38.46

3.4

3.8

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

174

356

3.17

38.44

1.0

80.56

84.25

ug/l

0.48

158

274

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1651

7545

1.43

37.90

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1051

4384

1.56

37.66

3.1

3.0

0.77

0.81

nmol/l

2.50

793

3390

(3022621) pH of Urine by Test strip

3509

17999

1.28

37.64

2.9

2.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

308

4189

0.47

37.46

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1937

9128

1.39

37.30

3.3

3.1

0.35

0.34

u/ml

0.82

1154

5140

(3023430) Cat dander IgE Ab [Units/volume] in Serum

889

3579

1.62

36.97

1.1

3.73

4.15

u/ml

0.32

367

1446

(3037756) Immunofixation for Serum or Plasma

1261

5496

1.50

36.94

1.5

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

935

3827

1.59

36.33

1.1

4.48

3.82

u/ml

0.39

444

1760

(3026389) Candida sp identified in Specimen by Organism specific culture

964

3978

1.58

36.20

1.4

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2337

11408

1.34

35.99

5.5

5.0

1.71

1.70

0.27

2214

10669

(40761535) Cells panel - Urine sediment

4320

22828

1.24

35.93

3.6

3.4

—

(3004451) EKG impression Narrative

381

1190

2.08

35.88

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1395

6244

1.46

35.78

1.3

3.85

3.74

mmol/l

3.25

1307

5858

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1920

0.26

35.48

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

1755

8205

1.40

35.42

4.8

4.6

3.88

mmol/l

0.07

1745

8133

(3008898) HLA-B27 [Presence]

2034

9825

1.35

33.56

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

968

4070

1.55

33.54

1.3

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

374

1199

2.03

32.93

2.2

2.3

20.57

219.58

ug/l

1.54

357

1144

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

339

1051

2.09

32.61

2.4

—

(3011288) Drugs identified in Urine by Screen method

1547

7185

1.40

32.45

3.1

3.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1763

8399

1.37

31.77

1.2

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1654

7801

1.38

31.69

2.0

2.3

0.02

0.03

g/l

1.32

1516

7157

(3034891) Synovial lining cells/100 cells in Synovial fluid

394

1307

1.96

31.58

1.5

3.30

3.90

0.40

297

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1690

8006

1.38

31.53

2.0

2.2

38.00

37.79

g/l

0.75

1475

7012

(3044290) Cell count panel - Cerebral spinal fluid

1303

5903

1.44

31.40

1.4

—

(3020650) Glucose [Presence] in Urine

238

646

2.39

31.33

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2265

11230

1.32

31.30

5.6

5.0

0.88

0.90

2.72

2147

10500

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2993

15418

1.27

30.88

10.5

9.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

957

4089

1.52

30.86

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

11352

66008

1.14

30.77

3.8

3.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2857

14645

1.28

30.68

1.4

1.3

27.29

31.02

iu/l

7.65

2388

12795

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1857

8974

1.35

30.56

1.7

1.6

6.94

7.26

iu/ml

0.02

341

1950

(3023183) Ammonium ion [Moles/volume] in Plasma

1310

5974

1.43

30.47

2.7

2.8

33.23

34.14

umol/l

0.75

1214

5382

(3004775) Volume in Urine collected for unspecified duration

571

2154

1.72

30.46

2.2

2.3

653.77

686.01

0.98

368

1499

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1028

4473

1.50

30.43

1.4

1.3

25.45

30.71

u/l

5.73

830

3663

(3010144) Erythrocytes [#/volume] in Synovial fluid

656

2578

1.65

30.10

1.4

135129.91

100205.07

e6/l

0.58

450

1780

(3000034) Microalbumin [Mass/volume] in Urine

632

2469

1.66

29.67

3.3

2.9

62.26

53.07

mg/l

0.26

459

1761

(3009466) Valproate [Moles/volume] in Serum or Plasma

984

4272

1.50

29.46

5.4

5.1

362.73

369.78

umol/l

0.78

859

3721

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1676

8017

1.36

29.45

1.1

4.69

6.02

u/ml

0.74

184

1071

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

373

1246

1.94

29.35

1.2

1.1

10.37

13.04

u/ml

0.16

113

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

453

1614

1.82

29.32

1.5

1.4

5.75

6.01

u/l

0.26

389

1355

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1358

6278

1.41

29.28

1.4

21.47

34.09

e6/l

1.48

1066

4828

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1358

6284

1.41

29.12

1.5

1629.30

2389.89

e6/l

0.41

1131

5073

(3017354) Segmented neutrophils/100 leukocytes in Blood

684

2741

1.62

29.09

3.0

3.4

57.83

57.07

0.40

599

2304

(3047181) Lactate [Moles/volume] in Blood

1845

8975

1.34

29.07

6.4

5.7

1.34

1.31

mmol/l

0.68

1651

7915

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1299

5966

1.42

29.06

1.2

47.47

42.81

u/ml

0.37

119

610

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

564

2150

1.70

29.01

1.2

1.3

2.01

2.16

mmol/l

2.08

520

1986

(3016750) Collection duration of Urine

444

1578

1.83

28.97

2.1

2.2

497.70

499.85

min

0.17

309

1201

(3001019) Free T4 and TSH panel - Serum or Plasma

3047

15851

1.26

28.92

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

566

2175

1.69

28.29

1.0

1.1

288.66

426.18

mg/l

0.51

507

1958

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

349

1160

1.95

27.89

1.3

4.16

4.21

umol/l

0.05

301

1076

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1015

4486

1.47

27.86

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1015

4487

1.47

27.83

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

219

605

2.35

27.82

1.2

350.97

309.58

pmol/l

0.22

155

451

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

594

2323

1.66

27.81

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

594

2323

1.66

27.81

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

594

2323

1.66

27.81

1.6

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2246

11325

1.30

27.41

1.1

12.09

6.19

u/ml

0.23

178

(1001926) Buprenorphine [Presence] in Urine by Screen method

1739

8463

1.34

27.33

2.3

2.4

—

(3044941) Cell count panel - Synovial fluid

985

4353

1.47

27.06

1.3

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1257

5817

1.41

26.97

4.0

3.2

25.26

26.82

mg/l

0.69

742

3684

(3014765) Yersinia sp identified in Stool by Organism specific culture

1705

8311

1.34

26.51

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

701

2892

1.58

26.49

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

288

912

2.05

26.34

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1705

8327

1.34

26.17

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

634

2564

1.61

26.05

3.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

393

1391

1.83

26.05

1.8

1.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

362

1248

1.88

26.03

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

362

1249

1.88

25.97

1.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

393

1393

1.83

25.93

1.8

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

745

3133

1.55

25.91

1.1

1.0

0.58

0.46

u/ml

0.18

222

801

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1505

7233

1.36

25.70

2.0

2.3

0.00

g/l

0.16

1369

6613

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

944

4185

1.47

25.55

1.1

123.49

117.84

5.37

848

3801

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

650

2658

1.59

25.52

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1684

8243

1.33

25.46

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

967

4315

1.46

25.32

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

219

2913

0.48

25.16

1.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

621

2525

1.60

24.98

3.1

2.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

397

1432

1.80

24.79

1.1

21.00

26.02

u/l

1.15

353

1295

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

361

1264

1.85

24.78

2.1

93.21

111.34

ug/min

0.22

292

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1153

5337

1.41

24.74

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

396

1430

1.80

24.64

1.1

80.93

86.91

u/l

0.83

355

1292

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1478

7137

1.35

24.49

2.1

2.4

0.00

g/l

-0.00

1365

6594

(3039443) Prostate specific Ag panel - Serum or Plasma

1160

5396

1.40

24.20

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

369

1312

1.83

24.16

1.5

23.35

26.23

umol/l

0.99

348

1248

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

545

2164

1.64

24.15

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1297

6155

1.37

24.01

1.5

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

331

1139

1.89

23.99

9.0

9.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

198

561

2.29

23.85

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

318

3674

0.56

23.17

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

263

846

2.02

23.14

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

174

474

2.38

22.90

2.5

2.4

7.56

7.42

mmol/l

0.15

109

280

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1425

6923

1.34

22.70

1.7

1.9

10.35

11.10

iu/l

0.04

511

2547

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

181

505

2.32

22.61

1.8

2.0

15.63

17.23

umol/l

1.16

181

505

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

988

4525

1.42

22.55

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

700

2997

1.52

22.51

1.1

39.25

32.41

au/ml

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1016

4685

1.41

22.33

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1225

5832

1.37

22.26

1.4

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1225

5841

1.37

22.05

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1225

5841

1.37

22.05

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

685

2933

1.52

22.04

1.1

72.54

65.90

au/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1202

5721

1.37

21.88

1.2

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

370

1364

1.76

21.57

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

205

3.10

21.15

1.7

1.8

42.52

48.50

umol/l

1.09

205

(3038515) Glucose [Moles/volume] in Venous blood

1137

5405

1.37

20.88

3.7

3.1

7.50

7.53

mmol/l

0.15

1116

5306

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

233

747

2.02

20.75

1.0

1.1

8.03

10.72

u/ml

1.00

128

425

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1203

5800

1.35

20.21

1.4

17.53

20.13

u/ml

0.26

115

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

426

1666

1.66

20.12

1.3

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

1196

5765

1.35

20.12

3.6

3.0

1.55

1.58

mmol/l

0.45

1171

5644

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

491

1991

1.60

20.10

1.8

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4855

27315

1.16

20.08

2.4

2.6

43.04

44.26

u/l

0.07

4090

23506

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

467

1872

1.62

20.03

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

464

1858

1.62

19.99

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

182

540

2.18

19.79

1.2

1.3

70.63

82.88

mu/l

0.25

137

404

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

541

2254

1.56

19.75

1.2

1.1

40.89

44.87

mg/l

1.00

427

1916

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

431

1700

1.65

19.72

1.3

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

151

414

2.36

19.68

2.7

3.0

15.11

14.74

ml/dl

0.72

139

386

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

458

1838

1.62

19.57

1.4

1.6

23.36

24.88

u/ml

0.21

376

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

280

978

1.86

19.51

1.2

0.31

g/l

0.79

214

781

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

523

2170

1.56

19.45

1.1

281.40

278.79

mg/l

0.08

450

1917

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

698

3081

1.47

19.45

1.2

59.92

63.78

u/l

0.70

625

2765

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

425

1678

1.64

19.38

1.2

1.1

1.06

1.07

ratio

0.43

166

563

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

935

4360

1.39

19.33

1.3

1.2

4.41

3.75

u/ml

0.78

398

1948

(3052851) Hemolysis interference index of Serum or Plasma

1699

8659

1.28

19.13

3.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1119

5384

1.35

19.07

1.3

290.01

270.99

u/ml

1.22

687

3574

(3032057) Clostridioides difficile [Presence] in Stool

175

520

2.18

18.98

1.8

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

539

2273

1.54

18.69

1.2

1.3

9.31

8.80

mmol/l

1.82

519

2163

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

828

3814

1.41

18.40

6.7

6.2

11.18

11.50

mg/l

1.26

748

3524

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

399

1576

1.64

18.20

2.5

871.15

1086.81

u/ml

1.13

391

1560

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

606

2640

1.49

18.06

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

400

1586

1.64

17.99

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

258

902

1.85

17.97

1.1

1.2

109.65

112.57

0.97

226

813

(3016879) Cocaine [Presence] in Urine

1990

10411

1.25

17.97

2.2

2.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

267

944

1.83

17.96

1.5

1.4

14.27

15.22

pmol/l

1.97

227

788

(3017817) Protein [Mass] in Urine collected for unspecified duration

574

2476

1.51

17.95

2.2

2.4

1.31

0.44

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

260

912

1.85

17.93

1.1

—

(3036603) Volume of Urine

465

1915

1.58

17.91

1.6

2058.22

1950.17

1.51

451

1864

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

501

2100

1.55

17.87

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

632

2784

1.47

17.84

1.7

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

301

1107

1.76

17.80

2.0

2.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

381

1500

1.65

17.62

1.4

1.5

8.39

8.38

ug/l

0.00

335

1370

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

522

5020

0.67

17.51

3.1

3.6

25.02

38.97

u/ml

3.04

502

4850

(40761539) Cells [Type] in Urine sediment by Light microscopy

202

659

1.99

17.26

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

940

4477

1.36

17.15

1.3

1.2

3.10

3.77

u/ml

0.64

319

1553

(3022689) Creatine [Moles/volume] in Urine

224

760

1.91

17.12

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

660

2958

1.45

17.08

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

318

1210

1.70

16.74

1.9

2.0

—

(3024928) Oxygen saturation in Venous blood

1183

5854

1.31

16.71

4.2

3.3

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

231

799

1.87

16.68

1.5

1.4

701.74

782.08

mu/l

0.11

222

757

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

318

1212

1.70

16.64

1.9

1.8

130.84

120.25

umol/l

0.23

158

619

(3000764) Benzodiazepines [Presence] in Urine

2101

11156

1.23

16.55

2.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1201

0.36

16.51

1.3

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

294

1099

1.74

16.49

1.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

294

1100

1.73

16.44

1.9

2.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

203

679

1.94

16.20

1.4

1.2

17.26

16.84

umol/l

0.63

185

597

(3027008) Opiates [Presence] in Urine

2109

11228

1.22

16.20

2.1

2.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

126

349

2.34

16.16

1.1

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

176

560

2.04

16.14

1.1

—

39.43

u/ml

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

232

814

1.85

16.05

1.5

1.4

73.79

72.61

0.59

223

772

(3033705) Calcium.ionized [Moles/volume] in Venous blood

684

3127

1.42

15.94

2.6

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

688

3149

1.42

15.93

1.2

1.1

100.25

96.10

3.58

646

2950

(3041354) Potassium [Moles/volume] in Venous blood

694

3186

1.41

15.80

2.6

2.3

4.04

4.05

mmol/l

0.20

689

3161

(3028300) Cannabinoids [Presence] in Urine

2109

11261

1.22

15.75

2.2

2.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

606

2718

1.45

15.67

1.5

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

693

3186

1.41

15.66

2.6

2.3

106.00

105.64

mmol/l

1.28

688

3160

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

427

1781

1.56

15.65

1.5

1.6

6.90

6.97

u/l

0.04

323

1449

(3033923) Metanephrine [Moles/time] in 24 hour Urine

173

554

2.02

15.61

1.2

1.1

0.63

3.23

umol/24h

0.55

293

(3006270) Folate [Moles/volume] in Blood

516

2251

1.49

15.37

1.2

1.1

358.96

370.04

nmol/l

0.55

432

1916

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

444

1876

1.54

15.37

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

393

1618

1.58

15.25

1.3

519.67

415.14

titre

0.17

111

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

425

1783

1.55

15.20

1.1

9.74

8.48

iu/ml

0.32

474

(3003338) MCHC [Mass/volume]

38964

258102

0.92

15.15

20.9

17.1

332.43

332.76

g/l

9.78

38765

256246

(1761482) Bacteria [#/volume] in Urine by Culture

1326

6753

1.28

15.11

4.3

3.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6437

46019

0.89

14.93

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

2486

13558

1.20

14.89

3.7

3.3

—

(3016018) Differential panel - Cerebral spinal fluid

674

3119

1.40

14.71

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

973

4775

1.32

14.64

4.3

3.0

66.78

64.58

2.58

968

4756

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

990

4879

1.32

14.47

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

770

3655

1.37

14.44

1.2

53.90

54.68

u/ml

0.03

250

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

163

527

2.00

14.38

1.2

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1077

5375

1.30

14.37

1.5

108.43

113.51

u/ml

0.76

311

1158

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

380

1580

1.56

14.18

1.3

71.38

77.31

titre

0.12

134

(3000093) Morphology [Interpretation] in Blood Narrative

580

2631

1.43

14.17

1.1

—

(3042517) Benzodiazepines panel - Urine

111

309

2.33

14.15

2.7

3.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1456

7564

1.25

14.07

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2602

14332

1.18

13.93

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

905

4438

1.32

13.72

1.1

15.12

11.77

au/ml

0.40

280

(3016650) Hepatitis A virus Ab [Presence] in Serum

988

4913

1.31

13.57

1.1

—

(3027944) Amphetamines [Presence] in Urine

2047

11064

1.20

13.53

2.2

2.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1730

9199

1.22

13.51

2.1

2.3

95.15

91.86

8.61

1654

8820

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

252

2673

0.61

13.45

1.4

3.89

3.74

ug/l

0.06

182

2226

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

408

1745

1.52

13.44

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

308

1236

1.62

13.37

1.1

103.78

97.86

2.69

243

992

(3036489) Thrombin time

2028

10965

1.20

13.37

2.0

2.1

21.44

21.51

0.13

1705

9606

(3036670) Protein [Mass/volume] in Synovial fluid

215

782

1.78

13.36

1.3

1.2

40.92

39.73

g/l

0.49

105

436

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

339

1395

1.58

13.26

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

190

670

1.84

13.06

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

190

670

1.84

13.06

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

190

670

1.84

13.06

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

190

670

1.84

13.06

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

202

2.60

13.01

2.1

1.9

1.35

1.34

umol/l

0.06

172

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.74

12.95

1.3

1.4

611.81

468.11

nmol/l

0.75

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

369

1558

1.54

12.92

1.1

1.15

1.07

u/l

0.34

161

716

(40762814) Titanium [Mass/volume] in Blood

134

420

2.07

12.90

2.3

5.10

3.36

ug/l

0.85

150

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

230

864

1.73

12.82

1.2

1.3

24.48

20.99

0.27

150

(3006462) Nitrate [Presence] in Urine

310

1263

1.59

12.68

3.3

3.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

335

1397

1.56

12.42

1.2

1.3

65.00

59.47

0.45

167

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1578

8388

1.22

12.39

2.5

187.79

189.33

0.28

1486

7953

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

197

721

1.77

12.05

1.3

110.78

131.85

nmol/l

1.21

153

525

(3010503) CD19 cells [#/volume] in Blood

399

1740

1.49

12.04

2.2

2.7

0.40

0.31

e9/l

0.26

389

1696

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

628

2976

1.37

12.00

2.4

2.3

—

(3013466) aPTT in Blood by Coagulation assay

140

2.87

11.98

1.1

36.36

37.41

0.37

122

(3024263) Appearance of Synovial fluid

343

1453

1.53

11.88

1.3

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

306

1265

1.57

11.81

2.0

1.9

151.43

145.78

0.54

286

1193

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

257

2.32

11.73

1.9

2.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

124

392

2.05

11.72

1.2

1.3

34.98

43.74

mg/l

1.69

108

334

(46235355) HIV 1 and 2 tests - Meaningful Use set

8176

48968

1.09

11.51

1.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.74

11.50

3.2

1.4

1.38

2.64

mu/l

1.09

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

139

462

1.95

11.47

2.4

2.6

58.31

47.66

mg/l

0.19

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

200

749

1.73

11.34

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

126

406

2.01

11.34

4.6

4.7

42.72

46.12

ug/min

0.22

327

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

4.41

11.33

6.0

5.2

0.27

0.22

mmol/l

0.45

(3020191) Ethanol [Moles/volume] in Serum or Plasma

531

2473

1.39

11.31

1.4

1.5

1.32

1.42

promille

0.79

382

1948

(3026470) Cobalt [Mass/volume] in Blood

374

1635

1.48

11.20

2.0

3.28

3.74

ug/l

0.66

338

1500

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

211

806

1.70

11.16

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

211

806

1.70

11.16

2.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

808

4031

1.30

10.94

1.5

1.4

0.28

0.38

nmol/l

3.26

587

3072

(3013005) Retinol [Moles/volume] in Serum or Plasma

277

1140

1.58

10.94

1.6

1.7

2.05

1.99

umol/l

0.61

262

1066

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

221

2.37

10.91

1.0

1.1

—

(3039000) Anion gap in Blood

1214

6369

1.24

10.86

7.6

6.7

11.37

11.17

mmol/l

1.21

1116

5724

(3011412) CD3 cells [#/volume] in Blood

585

2788

1.36

10.85

2.0

2.5

1.27

1.17

e9/l

1.14

538

2491

(3018572) Chloride [Moles/volume] in Blood

1214

6370

1.24

10.84

7.6

6.7

104.84

105.13

mmol/l

1.35

1116

5726

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4856

28422

1.12

10.80

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

349

1518

1.49

10.73

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

262

1074

1.58

10.55

2.3

2.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

165

598

1.79

10.50

1.6

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

189

716

1.71

10.34

1.1

13.95

3.05

u/ml

0.39

102

376

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

513

2418

1.38

10.22

1.2

186.67

178.43

titre

0.07

413

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.41

10.21

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

304

1303

1.51

10.07

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

510

2412

1.37

9.97

1.2

202.86

173.46

titre

0.13

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

420

1926

1.41

9.85

1.5

1.4

12.70

12.62

u/l

0.09

402

1864

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

349

1548

1.46

9.79

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

183

699

1.70

9.75

1.1

—

(3025577) Chromium [Mass/volume] in Blood

357

1592

1.45

9.74

2.0

2.1

2.15

2.38

ug/l

0.66

279

1355

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

185

709

1.69

9.74

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

150

2.59

9.71

1.1

—

(3001556) Androgen free Index in Serum or Plasma

210

2.31

9.60

1.7

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

345

1533

1.46

9.60

1.7

2.66

2.26

u/field

0.42

267

1085

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

422

1950

1.40

9.50

2.7

3.5

110.55

137.02

nmol/l

0.78

412

1919

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

322

1417

1.47

9.42

1.3

5.96

5.79

mmol/l

1.99

300

1337

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

173

658

1.70

9.38

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

205

816

1.63

9.37

1.0

—

(3003694) ABO and Rh group [Type] in Blood

12815

78692

1.07

9.34

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

220

892

1.60

9.34

1.1

92.20

88.38

0.89

103

416

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

183

709

1.67

9.28

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

285

2.09

9.28

1.9

2.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1150

6106

1.22

9.26

6.0

5.8

5002.47

1069.42

iu/ml

0.55

175

928

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

272

1161

1.52

9.23

2.2

2.4

54.29

51.11

umol/l

0.89

236

993

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1575

8619

1.19

9.21

2.5

2.6

3.80

3.58

g/l

6.45

1488

8247

(3027035) Albumin [Mass/time] in 24 hour Urine

239

2.19

9.21

1.4

1.2

227.82

266.79

mg/24h

0.09

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

183

712

1.67

9.15

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

132

468

1.83

9.09

1.0

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

628

3116

1.31

8.96

1.7

1.5

—

(3018133) Calcium [Moles/volume] in Urine

117

401

1.89

8.95

2.3

1.6

2.90

2.55

mmol/l

0.97

108

356

(3020874) Milk IgE Ab [Units/volume] in Serum

373

1706

1.42

8.93

1.0

1.1

2.26

2.33

u/ml

0.02

131

499

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

465

2208

1.37

8.93

1.7

1.9

3.79

3.78

mg/l

0.01

438

2116

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

214

872

1.59

8.92

1.1

95.16

89.00

1.24

102

410

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

569

2788

1.32

8.88

1.3

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

627

3115

1.31

8.87

1.7

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

136

492

1.79

8.80

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

128

457

1.81

8.65

1.3

82.27

289.46

ng/l

0.61

303

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

219

905

1.57

8.62

1.2

1.1

112.15

107.74

0.83

189

832

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

162

621

1.69

8.59

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

150

563

1.73

8.58

6.0

6.1

66.44

71.22

1.35

117

451

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

110

377

1.89

8.44

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

373

1727

1.40

8.37

1.0

—

(3008295) Osmolality of Serum or Plasma

548

2696

1.32

8.35

1.5

1.4

283.02

278.35

mosm/kgh2o

4.62

419

2115

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

172

676

1.65

8.32

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

265

1153

1.49

8.27

1.1

641.31

440.89

ng/l

0.28

274

(3019832) Treponema pallidum Ab [Presence] in Serum

3100

22334

0.89

8.11

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

231

981

1.53

8.10

2.0

1.6

65962.70

15102.88

u/ml

0.60

128

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

344

1581

1.41

8.07

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

884

4636

1.24

8.07

2.9

2.8

11795.13

2828.06

u/ml

0.43

243

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

100

2.78

8.02

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

315

1428

1.43

7.98

1.2

1.1

3.59

4.09

iu/ml

0.41

111

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

243

1047

1.50

7.97

1.3

1.2

—

(3007916) DNA double strand Ab [Titer] in Serum

102

348

1.90

7.96

1.3

100.00

164.69

titre

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

107

371

1.87

7.96

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

211

882

1.55

7.95

2.5

3.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1075

5763

1.21

7.93

2.8

3.5

469.01

899.27

u/ml

1.36

981

5226

(3011325) HIV 1+2 Ab [Presence] in Serum

116

2.62

7.87

1.1

1.0

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.95

7.83

1.6

1.5

156.81

139.39

nmol/l

0.21

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

434

2084

1.35

7.83

1.4

12.40

12.19

umol/l

0.27

411

1981

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

287

1285

1.45

7.79

2.4

2.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

376

1767

1.38

7.77

1.0

799.36

728.38

ng/l

2.13

266

1207

(3014051) Protein [Presence] in Urine by Test strip

1321

7232

1.19

7.77

2.6

2.4

—

(3028717) Thiamine [Mass/volume] in Blood

288

1.98

7.75

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

164

651

1.63

7.68

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

374

1760

1.38

7.67

1.0

379.12

325.32

ng/l

0.23

264

1258

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

376

1771

1.38

7.67

1.0

38.08

42.65

ng/l

1.33

259

1243

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

198

824

1.56

7.63

1.3

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

258

1137

1.47

7.61

1.6

1.7

30.32

29.29

umol/l

0.84

253

1087

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

506

2497

1.31

7.60

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

791

4128

1.24

7.58

3.0

2.5

13.30

13.15

4.03

780

4073

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

295

1.95

7.58

1.2

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1024

0.54

7.56

1.3

1.4

18.43

30.30

nmol/l

4.41

910

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.78

7.49

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

193

804

1.56

7.42

1.6

10.25

8.72

ug/l

3.93

193

804

(3017704) Immunofixation for Urine

318

1467

1.41

7.36

1.5

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

675

3473

1.26

7.34

1.6

2.0

3855.38

4186.82

titre

0.05

179

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

261

1162

1.46

7.33

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

326

1513

1.40

7.29

1.0

0.35

0.67

u/ml

0.67

326

(3035320) C reactive protein [Mass/volume] in Body fluid

421

2036

1.34

7.29

2.9

2.3

—

(3048879) Bone marrow aspiration report

188

782

1.56

7.28

1.5

1.9

—

(3028433) Virus identified in Specimen by Culture

217

932

1.51

7.28

1.1

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

3.42

7.27

1.0

1.1

55.95

63.61

mu/l

0.08

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

327

1524

1.39

7.15

1.7

1.6

—

(3019174) dRVVT (LA screen)

239

2.03

7.14

1.2

—

(21494755) Public health laboratory ask at order entry panel

4693

32896

0.92

7.09

1.4

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

336

1577

1.38

7.05

1.2

324.24

316.38

u/l

0.03

308

1478

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4470

26636

1.09

6.94

1.9

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

149

2.30

6.85

1.1

1.17

u/field

0.00

104

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

133

2.39

6.83

1.0

0.28

1.13

u/ml

0.59

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

103

373

1.79

6.76

1.1

1.0

0.59

0.33

u/ml

0.43

238

(40761995) Spermatozoa Progressive [#/volume] in Semen

946

0.55

6.74

3.1

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

945

0.55

6.72

6.3

6.5

—

(40768800) Prostate Pathology biopsy report

1007

5457

1.20

6.71

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

103

374

1.78

6.70

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

155

2.26

6.67

1.5

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

223

984

1.47

6.61

1.6

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

408

1995

1.33

6.61

2.1

2.6

558.09

527.12

e6/l

0.38

353

1661

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

265

1.93

6.57

1.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

234

1.99

6.54

1.2

42.67

50.44

mg/l

1.08

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1304

7241

1.17

6.54

1.3

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

215

944

1.48

6.54

2.1

1.9

163.02

171.60

0.59

199

896

(3023420) DNA double strand Ab [Units/volume] in Serum

624

3230

1.25

6.51

1.5

26.57

35.14

iu/ml

1.03

154

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

395

1928

1.33

6.49

2.2

2.6

0.26

0.23

e9/l

1.44

350

1659

(3038177) Helicobacter pylori Ab [Presence] in Serum

919

4966

1.20

6.34

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

357

1.78

6.34

1.4

1.3

0.21

0.28

nmol/l

0.85

246

(3022493) Free Hemoglobin [Mass/volume] in Plasma

262

1203

1.41

6.31

5.9

5.1

6129.17

1469.91

mg/l

1.34

173

873

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6675

40576

1.07

6.30

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

223

994

1.45

6.30

1.9

8.04

9.49

mg/l

3.61

171

799

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

289

0.22

6.28

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

398

1956

1.32

6.25

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.84

6.24

2.1

2.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

190

2.08

6.22

1.1

9.22

10.34

u/l

0.22

190

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

399

1966

1.32

6.16

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

100

370

1.75

6.15

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

439

2193

1.30

6.13

1.9

2.0

1.72

2.31

u/field

1.40

226

952

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

216

965

1.45

6.05

2.4

2.6

141.97

159.50

au/ml

0.18

119

(3023383) Lactate [Moles/volume] in Pleural fluid

184

797

1.50

6.02

1.3

3.72

3.45

mmol/l

0.59

167

736

(40757494) Bilirubin.total [Moles/volume] in Blood

312

1489

1.36

5.99

2.2

21.97

27.96

umol/l

0.42

139

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

703

5525

0.82

5.97

1.7

1.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

186

809

1.49

5.97

1.7

89.98

156.18

au/ml

1.39

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1437

10646

0.87

5.96

2.8

3.6

929.39

1988.78

u/ml

0.75

1213

9163

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

221

996

1.44

5.92

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

104

394

1.71

5.91

1.3

1.4

55.80

50.87

0.42

200

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

568

2948

1.25

5.84

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

632

3322

1.23

5.80

3.0

3.4

6.65

7.67

nmol/l

0.21

610

3227

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

107

412

1.68

5.75

2.2

3.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

326

1.77

5.70

1.5

1.6

101.24

114.21

ug/l

0.58

267

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

312

1.78

5.69

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

125

503

1.61

5.68

1.0

1.1

0.57

1.17

u/ml

0.58

421

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3700

22075

1.09

5.62

1.4

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

248

1.88

5.60

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

138

2.21

5.57

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

306

1.78

5.49

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

246

1147

1.39

5.49

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2153

15473

0.90

5.48

2.0

1.9

—

(3003181) Sodium [Moles/volume] in Urine

857

4671

1.19

5.45

1.4

64.53

62.59

mmol/l

0.68

683

3679

(3006922) Hepatitis E virus Ab [Presence] in Serum

425

2150

1.28

5.45

1.1

—

(3023410) Appearance of Cerebral spinal fluid

561

2933

1.24

5.44

1.6

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.53

5.42

1.0

1.1

159.95

200.30

pmol/l

0.44

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

233

1.89

5.39

1.0

0.05

0.17

u/ml

1.02

150

(3014599) Egg white IgE Ab [Units/volume] in Serum

345

1701

1.31

5.37

1.0

1.48

1.88

u/ml

0.20

373

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

113

451

1.62

5.33

1.1

3.87

3.66

pmol/l

0.04

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.24

5.33

1.1

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

244

1.86

5.28

1.2

1.6

4.41

5.15

nmol/l

0.82

234

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

135

564

1.55

5.27

1.2

59.05

36.39

mg/l

0.19

418

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

103

403

1.66

5.26

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.82

5.25

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

147

627

1.52

5.24

1.4

22.70

22.84

0.02

128

520

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

101

394

1.66

5.22

1.3

1.4

408543.93

196315.10

nmol/l

0.46

325

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.47

5.19

1.1

1.2

4364.29

2788.33

ng/l

0.22

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

336

1.72

5.18

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

262

2271

0.75

5.13

1.1

1.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

201

1.93

5.10

1.2

32.31

20.75

0.54

(3016228) CD19 cells/100 cells in Blood

246

1164

1.37

5.06

1.9

2.1

9.73

8.21

0.86

241

1135

(3036782) Glucose [Moles/volume] in Pleural fluid

482

2500

1.25

5.06

1.3

6.46

6.26

mmol/l

0.75

441

2322

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

380

1916

1.29

5.04

1.3

14.03

14.33

u/l

0.10

353

1765

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

469

2428

1.25

5.01

1.4

1.3

528.48

505.27

u/l

0.06

440

2308

(21494814) CD8 cells/100 lymphocytes in Specimen

241

1139

1.37

5.00

1.8

2.1

—

(3051339) Copper [Moles/volume] in Blood

132

2.16

5.00

1.1

1.2

17.28

16.65

umol/l

0.36

112

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

384

1.65

5.00

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

119

490

1.57

4.98

1.3

139.33

161.14

titre

0.08

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

268

1.79

4.98

2.6

2.3

1.14

1.13

mmol/l

0.01

188

(3009015) Lactate [Moles/volume] in Synovial fluid

283

1.76

4.94

1.3

1.2

5.62

6.31

mmol/l

0.48

146

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

153

668

1.48

4.91

1.4

1.6

0.34

0.40

ug/l

1.40

448

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

404

2062

1.27

4.88

1.8

2.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

769

4199

1.19

4.85

1.1

3.45

2.92

u/ml

0.38

342

2079

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

242

1.82

4.85

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

225

1058

1.38

4.83

3.0

3.1

6.95

7.97

mg/l

1.67

166

856

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

426

2191

1.26

4.83

1.8

2.1

15.28

15.42

0.10

415

2125

(1175426) CD3 cells/100 lymphocytes in Blood

432

2226

1.26

4.82

1.8

2.1

72.00

72.81

0.49

416

2132

(3039744) RNA polymerase III Ab [Units/volume] in Serum

238

1.82

4.81

1.0

1.1

9.71

3.13

u/ml

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

189

865

1.42

4.76

1.3

1.4

56.49

54.62

0.27

157

741

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

440

2280

1.25

4.69

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.31

4.68

1.1

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

436

2258

1.25

4.68

1.2

—

(3016038) Potassium [Moles/volume] in Urine

344

1731

1.29

4.67

1.3

1.2

32.37

34.35

mmol/l

0.90

292

1495

(40768441) Liver Pathology biopsy report

425

2195

1.25

4.67

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

439

2277

1.25

4.65

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

198

918

1.40

4.64

1.8

2.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

439

2278

1.25

4.63

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

435

2256

1.25

4.61

1.2

—

(3042733) HLA Ab [Presence] in Serum

223

1056

1.37

4.61

5.3

5.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

763

4184

1.18

4.60

2.0

2.3

7.58

7.05

titre

0.05

139

(3029075) Extractable nuclear Ab panel - Serum

183

839

1.41

4.58

1.1

—

(3027874) Urate [Moles/volume] in Urine

2.46

4.56

1.0

1.1

1.58

10.05

mmol/l

0.51

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

435

2261

1.25

4.53

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.39

4.46

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

208

984

1.37

4.36

6.0

6.4

25.27

25.04

mmol/l

0.39

194

884

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

228

1.79

4.30

1.3

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

233

1.78

4.29

1.4

1.3

1.05

1.50

ml/s/173m2

0.65

153

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

173

1.91

4.25

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.45

4.25

1.3

1.1

—

(3025130) Human papilloma virus identified in Specimen

511

3993

0.83

4.23

1.5

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

244

1191

1.33

4.19

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

188

1.86

4.17

1.3

1.1

—

(40763791) Oxygen content in Venous blood by calculation

2.51

4.15

7.5

6.1

12.11

12.44

ml/dl

0.13

(3047189) Immunofixation for 24 hour Urine

253

1244

1.32

4.13

1.6

1.9

—

(40768446) Kidney Pathology biopsy report

245

1201

1.32

4.09

1.6

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

699

3854

1.18

4.02

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

650

3571

1.18

3.91

1.5

1.4

34.05

33.10

g/l

1.14

595

3228

(21491868) Cryoglobulin [Mass/volume] in Serum

210

1015

1.34

3.89

1.1

1.2

0.71

0.52

g/l

0.19

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.57

3.85

1.7

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

159

736

1.40

3.85

2.0

1.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

108

464

1.51

3.84

1.4

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

347

1796

1.25

3.83

1.2

77.37

94.11

u/l

3.43

306

1574

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

166

1.87

3.82

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

367

2929

0.81

3.81

3.2

3.9

29.12

51.32

u/ml

3.64

362

2903

(3029396) Erythrocyte agglutination [Presence] in Blood

549

0.57

3.80

1.9

2.8

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

219

1.74

3.76

1.0

1.93

1.97

u/ml

0.01

164

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

327

1686

1.26

3.74

1.7

2.2

99.84

97.51

0.57

291

1595

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

152

1356

0.72

3.73

1.3

1.5

9.40

7.96

mmol/l

7.93

142

1303

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

122

2.02

3.73

1.0

9.96

14.06

u/ml

0.49

103

(3034426) Prothrombin time (PT)

206

1001

1.33

3.70

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

130

586

1.44

3.66

1.2

1.1

82.28

75.43

0.69

165

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.23

3.66

1.0

—

(3045716) Anion gap in Serum or Plasma

253

1268

1.29

3.65

3.0

2.3

9.34

9.87

mmol/l

1.68

247

1230

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

261

1.66

3.61

1.1

21.55

20.54

u/l

0.14

182

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

361

1893

1.24

3.58

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

130

589

1.43

3.58

1.2

97.70

87.23

1.61

173

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

213

1.73

3.57

1.7

1.5

0.68

2.13

mg/l

3.60

136

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

283

1.62

3.51

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

1.77

3.51

1.1

—

(40765096) Chromosome analysis panel by Banding

167

793

1.36

3.51

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

253

1276

1.28

3.50

1.1

1532.52

1560.21

miu/ml

0.15

253

1276

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

169

1467

0.74

3.50

1.1

—

(3015183) Erythrocyte sedimentation rate

296

1526

1.26

3.43

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

393

1.52

3.41

1.1

10.22

3.72

u/ml

0.28

278

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

136

1.90

3.38

1.0

0.33

0.38

u/ml

0.07

122

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

0.65

1.05

mg/l

0.64

135

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

2.30

2.67

mg/l

0.19

142

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

2.98

2.00

mg/l

0.51

153

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

0.96

2.12

mg/l

2.01

123

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

1.64

2.06

mg/l

0.19

133

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

4.57

3.95

mg/l

0.23

131

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

0.70

1.59

mg/l

1.41

124

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

1.75

1.97

mg/l

0.17

144

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

207

1.72

3.38

1.7

1.5

2.28

2.18

mg/l

0.06

137

(3036180) Methadone [Presence] in Urine

273

1400

1.26

3.32

2.8

2.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

334

1753

1.23

3.32

1.2

21.37

25.25

u/l

1.04

288

1512

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

265

1359

1.26

3.24

1.2

—

(3012441) Differential panel - Pleural fluid

505

2767

1.18

3.22

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4819

29632

1.06

3.21

2.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

186

1.74

3.21

2.6

2.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.24

3.21

1.3

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

213

1064

1.30

3.21

1.7

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

103

2.01

3.16

1.2

1.1

1.95

0.96

u/field

0.54

(3011897) Casein IgE Ab [Units/volume] in Serum

395

1.49

3.16

1.1

1.2

1.48

1.63

u/ml

0.04

390

(3002619) Bacteria identified in Specimen by Culture

124

572

1.40

3.14

1.3

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

207

1.69

3.13

1.1

1.0

0.11

0.59

u/ml

1.24

122

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

208

1040

1.30

3.12

2.5

2.0

63.80

57.90

ug/l

0.55

203

1015

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

154

738

1.35

3.10

1.3

37.28

38.79

0.17

100

500

(40763480) Human metapneumovirus Ag [Presence] in Specimen

122

1.91

3.10

1.2

1.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.51

3.09

1.1

1.3

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

3.96

3.08

1.1

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

176

863

1.32

3.05

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

305

1.55

3.03

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

258

1331

1.26

3.03

31.5

27.1

120.00

115.58

ug/l

0.51

212

1109

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1741

12248

0.92

3.02

1.9

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

443

1.45

2.98

1.6

1.8

61.07

57.72

pmol/l

0.08

377

(3026250) Tacrolimus [Mass/volume] in Blood

266

1382

1.25

2.95

35.4

35.8

7.51

7.31

ug/l

0.85

234

1271

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

428

1.45

2.95

1.5

1.6

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

125

1.86

2.91

1.6

1.4

0.17

0.24

u/l

0.15

(3044590) Delta aminolevulinate [Moles/volume] in Urine

4.48

2.88

1.0

1.1

18.33

14.00

umol/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

487

2690

1.17

2.87

4.0

5.0

103.09

111.61

u/ml

0.09

159

838

(3041918) Cholesterol [Moles/volume] in Pleural fluid

107

490

1.41

2.86

1.3

1.2

1.50

1.69

mmol/l

0.78

302

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.19

2.83

1.2

1.0

1.39

1.30

u/field

0.12

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1421

10047

0.91

2.79

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

101

460

1.42

2.79

1.1

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

130

620

1.36

2.75

1.4

1.3

114.11

108.44

0.97

123

590

(3033942) Copper [Moles/time] in 24 hour Urine

109

1.90

2.75

1.0

1.1

0.28

0.55

umol/24h

0.62

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1392

8235

1.10

2.74

2.2

3885.51

5019.65

u/l

0.72

414

3120

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.90

2.74

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

178

1.67

2.63

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

209

1072

1.26

2.63

2.7

2.9

28.97

28.43

umol/l

0.27

154

819

(3014148) Varicella zoster virus Ab [Titer] in Serum

640

3635

1.14

2.62

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

572

3224

1.15

2.62

1.5

2679.91

3599.88

e6/l

0.57

423

2338

(3022229) Phosphate [Moles/volume] in Urine

111

1.87

2.62

2.8

1.4

17.16

18.84

mmol/l

0.26

(3028308) Erythrocytes [#/volume] in Pleural fluid

521

2917

1.16

2.62

1.5

1.4

82360.88

49806.08

e6/l

1.19

319

1745

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

114

538

1.37

2.60

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

224

1.59

2.59

1.0

0.03

0.19

u/ml

1.18

128

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

114

539

1.37

2.57

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

150

1.73

2.57

1.0

0.51

1.37

u/ml

0.48

119

(3051611) Lipemic interference index of Serum or Plasma

543

3056

1.15

2.55

3.4

3.3

—

(4281824) Cell count and differential, peritoneal fluid

429

3238

0.86

2.55

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

308

1.49

2.55

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

444

2463

1.17

2.53

1.5

1.00

0.95

g/l

2.49

439

2449

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

108

1.86

2.52

1.2

1.3

1.05

1.09

u/field

0.10

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.07

2.50

1.9

1.5

135.12

272.67

nmol/l

1.48

(3035880) pH of Pleural fluid

274

1459

1.22

2.48

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

222

1.57

2.47

1.0

0.63

0.59

u/ml

0.03

163

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

327

1772

1.20

2.47

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

826

4790

1.12

2.45

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

114

1.82

2.44

1.1

0.05

0.42

mg/l

0.49

101

(4035726) Immunohistochemistry procedure

4213

26022

1.05

2.44

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

306

1.48

2.44

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

113

539

1.36

2.43

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

148

1.71

2.42

1.6

1.7

0.66

0.73

umol/l

0.33

114

(3008536) Aspergillus sp Ab [Presence] in Serum

118

568

1.35

2.40

1.7

2.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.06

2.39

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

182

932

1.26

2.37

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

4.53

2.36

1.1

1.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.09

2.36

8.0

8.5

41.75

44.53

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

230

1.55

2.35

1.0

0.02

1.86

u/ml

0.68

134

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

614

3508

1.13

2.35

1.9

18.49

25.91

ug/l

5.14

602

3441

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1060

6247

1.10

2.33

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

146

729

1.30

2.32

1.3

477.94

247.71

ug/l

0.59

389

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.03

2.31

9.5

8.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

823

4791

1.11

2.30

1.1

—

(40768806) Pleura Pathology biopsy report

493

2780

1.15

2.30

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

245

1919

0.83

2.28

1.7

1.8

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

171

1.63

2.27

1.4

1.3

25.93

15.16

pmol/l

0.72

143

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

222

1.55

2.26

2.6

2.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

290

1.47

2.26

1.2

1.1

1.87

2.95

umol/24h

0.41

290

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.89

2.25

1.0

0.23

0.19

u/ml

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

207

1.56

2.25

5.1

5.5

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

202

1.57

2.24

2.5

3.2

2.36

2.25

mg/l

0.14

172

(3045142) Bone marrow Pathology biopsy report

551

3138

1.14

2.23

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

334

1.43

2.22

1.4

1.3

910.95

79.84

u/l

0.80

235

(3044416) Complement C4 [Mass/volume] in Pleural fluid

118

1.76

2.21

1.4

1.2

0.06

0.07

g/l

0.73

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

234

1832

0.83

2.19

2.5

2.8

42.52

38.51

2.62

155

963

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

199

1.56

2.16

1.7

1.3

23.66

21.38

mmol/l

1.84

146

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

116

568

1.32

2.15

1.3

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

195

1.56

2.11

1.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

250

1344

1.20

2.11

3.4

3.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.16

2.08

1.1

1.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

181

1.57

2.06

1.2

1.9

1.38

0.53

0.98

138

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

302

1.44

2.05

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

347

0.62

2.05

5.7

7.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

161

1.61

2.04

1.1

1.0

1.30

1.33

u/ml

0.01

115

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

412

1.37

2.02

2.4

1.9

—

(3050794) Legionella sp Ab [Presence] in Serum

250

1.48

2.01

1.1

—

(3007463) Buprenorphine [Presence] in Urine

117

1.72

2.01

10.0

6.7

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.64

2.00

2.0

2.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

147

1.63

1.99

1.0

0.10

0.76

u/ml

2.29

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.12

1.99

1.2

1.1

2.94

2.15

0.35

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

584

0.71

1.99

2.1

1.8

2.68

3.60

ug/l

0.34

350

(3032868) Hemoglobin electrophoresis panel in Blood

230

1.49

1.97

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

178

1.56

1.97

1.6

1.4

308.49

344.04

umol/24h

0.62

178

(3020123) Porphyrins [Interpretation] in Serum or Plasma

163

1.59

1.96

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

257

1.46

1.95

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.04

1.94

1.2

1.1

—

(40768793) Breast Pathology biopsy report

929

6565

0.91

1.93

1.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

200

1.52

1.92

1.2

1.1

14.06

15.77

nmol/l

0.27

(3001729) Color of Synovial fluid

216

1.50

1.91

1.2

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

934

5533

1.09

1.91

1.7

1.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.34

1.90

1.2

1.1

1630.00

2331.94

titre

0.67

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

154

799

1.25

1.87

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.88

1.86

1.2

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

130

1.64

1.85

1.1

1.0

4.85

6.06

u/ml

0.24

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

389

2199

1.15

1.83

2.2

2.6

763.68

657.59

e6/l

1.84

374

2127

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

315

1.40

1.83

1.4

73.31

71.09

0.23

258

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

4.62

1.82

1.0

0.00

u/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

354

1.37

1.81

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

141

1.61

1.81

1.1

—

(36303858) Crystals [Presence] in Urine

2.27

1.80

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2279

15552

0.95

1.80

2.6

3.5

37.52

51.63

u/ml

2.36

2184

15039

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

132

1.62

1.76

1.0

0.20

0.15

u/ml

0.16

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

173

1.53

1.76

5.3

5.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

361

2039

1.15

1.74

1.3

1.49

1.55

g/l

4.38

361

2039

(44786800) Granulocytes/100 leukocytes in Body fluid

321

1.37

1.67

1.3

27.77

23.73

0.38

253

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

261

1.41

1.66

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

245

1.43

1.66

1.6

1.3

8.63

14.86

pmol/l

1.26

209

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

224

1.44

1.64

1.1

15.10

17.86

iu/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

388

0.68

1.62

1.7

2.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

163

867

1.22

1.62

1.7

1.4

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.40

1.59

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

391

1.32

1.59

1.4

14.71

11.42

0.50

190

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

439

0.71

1.58

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.83

1.57

1.6

1.1

23.53

31.94

nmol/24h

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.95

1.57

1.6

1.4

2.25

1.99

mmol/24h

0.39

(3042301) Urate [Moles/volume] in Synovial fluid

1.95

1.57

1.0

356.86

365.46

umol/l

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

132

1.57

1.55

1.2

1.3

1.89

1.69

mg/l

0.39

112

(3042111) Morphology [Interpretation] in Bone marrow Narrative

774

4601

1.09

1.53

1.5

1.6

—

(3024932) HLA-DR beta [Type]

193

1050

1.19

1.53

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

239

1.41

1.51

1.2

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

134

0.48

1.50

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

113

1.60

1.48

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

390

1.31

1.48

3.1

2.6

62.30

75.42

pmol/l

0.37

336

(21494815) CD4 cells/100 lymphocytes in Specimen

454

2635

1.12

1.47

1.9

2.2

40.11

37.95

2.20

438

2594

(3011544) Albumin [Mass/volume] in Pleural fluid

246

1.39

1.47

1.1

1.2

18.48

17.10

g/l

0.67

225

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

219

1.42

1.46

1.3

1.5

30.73

40.14

0.82

152

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

119

1.58

1.45

1.0

0.13

0.07

u/ml

0.24

(3019768) Coxiella burnetii Ab [Presence] in Serum

166

1.48

1.44

1.3

1.1

—

(3013762) Body weight Measured

132

0.49

1.44

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

319

1.34

1.44

1.9

1.7

1.61

1.71

mg/l

0.22

266

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.72

1.44

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

262

1472

1.15

1.42

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.33

1.41

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

110

1.59

1.39

17.9

13.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.90

1.39

1.5

1.3

0.63

0.60

u/field

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

173

1.46

1.39

1.1

38.53

88.92

u/l

0.72

137

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.77

1.38

1.2

1.6

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

195

1.43

1.37

1.3

1.5

10.19

12.78

0.37

145

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

110

574

1.24

1.36

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

131

697

1.22

1.35

1.2

1.3

—

(40768795) Lymph node Pathology biopsy report

501

2940

1.10

1.35

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

293

2150

0.88

1.34

16.7

18.9

1397.50

2933.79

nmol/l

1.05

280

2062

(3008116) Ketones [Moles/volume] in Urine by Test strip

112

587

1.24

1.34

1.6

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

202

1.41

1.32

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

235

1.38

1.32

1.1

—

(21494434) Karyotype in Bone marrow

417

2432

1.11

1.28

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

209

1.39

1.28

1.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

147

797

1.19

1.27

1.4

2.61

2.76

0.09

121

674

(3024471) HLA-A [Type]

194

1078

1.17

1.26

1.0

—

(3003577) Lead [Moles/volume] in Blood

243

1.36

1.25

1.4

0.19

0.21

umol/l

0.08

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

350

1.29

1.25

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1400

9564

0.95

1.25

1.5

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

238

1.36

1.24

1.4

1.1

9.95

9.40

mg/l

0.10

221

(3007542) Rye IgE Ab [Units/volume] in Serum

135

1.49

1.23

1.0

0.73

0.41

u/ml

0.22

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.03

1.22

1.0

—

(3017509) Phencyclidine [Presence] in Urine

331

1.29

1.17

1.7

1.8

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.73

1.14

1.0

0.02

0.24

u/ml

0.73

(3049233) Organic acids panel - Urine

2.38

1.13

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

145

796

1.18

1.12

2.0

1.9

21.39

42.25

u/l

2.67

136

713

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

157

868

1.17

1.12

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

166

1.40

1.10

1.2

1.4

3.40

1.12

0.89

115

(3009677) Dengue virus Ab [Presence] in Serum

102

1.52

1.08

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

422

2492

1.10

1.07

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

101

787

0.83

1.06

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

217

1.34

1.06

1.2

87.96

111.15

ug/l

0.75

127

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

168

939

1.16

1.06

1.4

60.57

61.83

0.17

132

779

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

371

1.26

1.05

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

114

618

1.19

1.04

9.6

8.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

312

1819

1.11

1.03

5.6

6.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

239

1373

1.13

1.02

1.6

1.5

711696.43

2281592.18

iu/ml

2.83

(3005011) Chlamydia sp Ab [Titer] in Serum

391

1.24

1.01

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

468

2788

1.09

0.99

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

283

2033

0.90

0.98

12.2

13.5

783.30

1330.61

nmol/l

0.58

271

1962

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

226

1.32

0.98

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

131

724

1.17

0.97

1.4

20.12

22.74

0.52

117

655

(3026692) Albumin [Mass/volume] in Peritoneal fluid

128

707

1.17

0.96

1.3

1.4

14.71

13.22

g/l

0.96

102

530

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.82

0.96

1.1

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

215

1233

1.13

0.96

2.8

2.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

269

1934

0.90

0.95

1.4

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.77

0.94

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

325

1911

1.10

0.93

1.2

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.68

0.93

1.0

0.50

0.69

u/ml

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

117

645

1.17

0.91

2.3

2.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

350

1.24

0.91

2.6

2.3

0.67

0.55

u/field

0.38

350

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

191

1093

1.13

0.90

1.8

2.0

27.62

29.98

1.40

181

1027

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

128

713

1.16

0.89

9.5

8.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

393

1.22

0.87

1.6

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.53

0.87

1.5

1.6

154.91

122.90

ug/l

0.20

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

335

1983

1.09

0.86

1.8

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

299

0.76

0.86

2.1

2.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

676

4114

1.06

0.85

2.6

2.8

491.35

772.56

u/ml

0.31

665

4063

(40758358) Immune stain study

125

1.40

0.85

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

422

2949

0.93

0.84

1.4

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

109

1.43

0.83

1.5

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.51

0.83

2.7

3.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

450

1.19

0.81

1.3

1.6

—

(3018001) Oat IgE Ab [Units/volume] in Serum

188

1.31

0.81

1.1

1.0

0.30

0.26

u/ml

0.09

113

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.49

0.79

1.0

0.01

0.18

u/ml

—

(3006245) CD3-CD19+ cells/100 cells in Blood

192

1111

1.12

0.79

1.8

2.1

10.48

10.18

0.13

177

1025

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

138

0.66

0.79

7.8

9.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.31

0.78

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.31

0.78

1.0

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

2.31

0.78

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

163

1188

0.89

0.78

1.7

2.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

264

1.25

0.78

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

125

705

1.15

0.77

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.46

0.76

1.1

—

mmol/l

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

191

1.29

0.74

2.3

14.11

17.41

0.36

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

497

1.17

0.73

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.62

0.72

1.1

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

158

1.31

0.71

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

362

1.20

0.70

1.2

1.9

6.46

7.33

mmol/l

2.01

126

(3000060) B lymphocytes [#/volume] in Blood

141

808

1.13

0.70

1.7

2.0

253.61

746.17

e6/l

0.84

412

(3013862) HLA-DP [Type]

126

0.67

0.69

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

159

1.30

0.68

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

159

1.30

0.68

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.68

0.68

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

125

0.67

1.0

—

(40760410) HLA-B [Type] by High resolution

125

0.67

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

112

635

1.14

0.67

1.1

7.00

7.57

mg/g

0.41

105

601

(3044007) Cell count panel - Peritoneal fluid

115

844

0.88

0.65

2.2

1.8

—

(3008607) Semen analysis panel

259

1.22

0.65

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

101

0.64

0.65

2.6

2.2

—

(3051651) Icteric interference index of Serum or Plasma

297

1779

1.08

0.64

4.2

3.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

138

999

0.89

0.63

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

119

869

0.89

0.63

1.1

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

243

1.23

0.62

2.2

2.3

63.13

58.01

0.36

151

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2978

19713

0.98

0.62

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4623

29391

1.02

0.61

1.9

1.7

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.45

0.60

1.0

1.1

0.02

0.22

g/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.41

0.60

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

406

1.16

0.58

1.2

1.3

1.22

1.38

mmol/l

0.11

260

(40757373) Influenza virus identified in Isolate

546

1.14

0.57

2.1

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

347

1.18

0.57

1.3

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.58

0.57

1.0

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

147

1.28

0.56

1.3

1.5

167.50

178.17

ug/g

0.14

125

(3006598) pH of Arterial cord blood

0.62

0.55

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.37

0.55

6.1

5.9

1.18

1.31

mg/l

0.13

(3006969) Lambda light chains [Mass/volume] in Urine

1.44

0.55

1.0

1.1

0.01

0.07

g/l

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.46

0.53

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.46

0.53

1.9

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.46

0.53

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.46

0.53

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.46

0.53

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.46

0.53

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

278

1.19

0.53

1.3

1.2

—

(3034614) HLA Ag [Interpretation]

1.41

0.53

1.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

569

0.88

0.52

2.2

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

184

1093

1.09

0.52

1.8

1.9

—

(3007700) Barley IgE Ab [Units/volume] in Serum

120

1.29

0.52

1.0

0.14

0.50

u/ml

0.79

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

103

0.69

0.52

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

118

686

1.11

0.52

1.1

1.2

—

(46236302) HLA-C [Type] by High resolution typing

125

0.72

0.51

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

202

1.22

0.51

4.1

4.4

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

161

1.25

0.51

1.1

1.2

—

314.00

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

380

0.85

0.50

6.4

8.1

0.40

0.39

umol/l

0.03

346

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.69

0.49

2.5

2.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.51

0.48

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

123

0.74

0.47

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1649

10945

0.97

0.47

1.9

1.8

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.46

0.47

1.0

1.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.46

0.47

1.0

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

105

1.29

0.47

1.1

246.49

265.62

nmol/l

0.16

105

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4581

30073

0.98

0.46

3.3

4.2

19.41

26.20

ug/l

0.80

3600

24246

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.34

0.45

1.1

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

222

0.82

0.45

2.5

2.0

2.55

3.12

mg/l

0.51

214

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

322

2205

0.94

0.45

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.70

0.44

4.0

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

479

1.12

0.44

4.8

5.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

171

1.21

0.43

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.42

0.0

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.42

0.42

1.0

1.1

—

(3024316) Viscosity of Plasma

148

1.22

0.42

1.3

1.9

1.66

1.67

mpas

0.05

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.29

0.41

1.1

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.39

0.41

1.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.28

0.40

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

130

774

1.09

0.39

1.6

1.8

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.41

0.38

1.8

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

156

1.20

0.38

3.8

3.5

—

(3052592) Norovirus Ag [Presence] in Stool

559

1.10

0.37

1.2

1.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.49

0.37

1.2

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

132

923

0.93

0.37

2.0

1.8

8351.56

10708.57

e6/l

0.29

490

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

351

1.12

0.36

1.2

1.3

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.25

0.36

1.1

1.0

5.55

4.97

mmol/l

0.34

(4034850) Laboratory test

1524

9655

1.02

0.35

10.9

9.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

478

2976

1.04

0.35

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

1.39

0.35

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

684

0.92

0.34

1.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

153

1.18

0.32

12.5

10.3

754.53

239.71

e6/l

0.41

112

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

153

1.18

0.32

1.0

1.1

48.89

27.76

u/ml

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

136

0.81

0.32

2.8

3.7

23.57

18.58

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

294

1.12

0.31

2.2

2.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

198

0.85

0.31

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

626

3931

1.03

0.30

1.4

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.29

0.30

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

155

1.17

0.29

1.4

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.29

0.28

1.8

3.0

—

(3014891) Appearance of Pleural fluid

360

0.90

0.28

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

152

1043

0.94

0.28

2.0

7388.36

1959.57

e6/l

0.56

112

699

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.75

0.28

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

498

3124

1.03

0.27

2.4

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.23

0.27

1.9

2.3

0.07

0.15

ug/l

1.50

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

250

1548

1.05

0.27

1.3

—

(4212803) Bone marrow aspirate examination

242

1.12

0.27

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.79

0.26

1.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1025

6766

0.98

0.25

1.4

123.41

138.08

pmol/l

0.46

996

6616

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

221

0.88

0.25

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

255

0.89

0.25

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

124

0.83

0.24

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

122

1.17

0.23

1.5

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

122

1.17

0.23

1.0

—

(3008838) Polymorphonuclear cells/100 leukocytes in Peritoneal fluid

1.29

0.23

1.4

1.9

—

22.29

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.22

0.0

2.9

—

3.75

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

627

0.94

0.21

2.7

2.8

84.54

109.35

ng/l

0.89

275

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

5.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

434

1.07

0.21

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

285

1.09

0.20

1.4

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

237

1588

0.97

0.19

4.2

6.4

1127.71

2957.02

u/ml

0.45

344

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.17

0.19

1.0

0.12

0.44

u/ml

1.02

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.24

0.18

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

175

0.89

0.18

1.1

2.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.13

0.17

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.75

0.17

4.4

3.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

221

0.91

0.17

2.0

3.1

4.93

396.47

pmol/l

0.68

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

176

1099

1.04

0.16

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.76

0.16

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

192

0.91

0.14

1.4

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

103

638

1.04

0.14

1.5

1.3

25.71

37.63

g/l

0.66

488

(3021162) Amylase [Enzymatic activity/volume] in Specimen

476

1.05

0.12

3.3

2.7

1788.71

1795.36

u/l

0.00

433

(3045462) Protein/Creatinine [Ratio] in Urine

211

1.07

0.11

4.9

3.5

35.70

50.09

g/mol

0.50

191

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

208

1377

0.98

0.10

1.4

1.5

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.14

0.10

1.0

712.00

268.77

u/l

0.37

(40758292) HTLV I+II Ab panel - Serum

504

1.04

0.10

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

208

1376

0.98

0.10

1.4

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

479

1.04

0.10

7.0

6.9

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.16

0.10

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.12

0.10

1.0

—

(3000285) Sodium [Moles/volume] in Blood

346

1.05

0.09

1.2

—

(3041184) Isoniazid [Presence] in Urine

1.14

0.09

2.2

2.6

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

107

0.91

0.08

1.0

0.05

0.54

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

0.83

0.08

1.2

1.4

—

(3040794) Aluminum [Moles/volume] in Urine

1.10

0.08

2.1

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

168

1110

0.98

0.08

2.3

2.5

132.70

152.10

nmol/l

2.03

154

944

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

180

1142

1.02

0.08

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.10

0.07

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

120

1.08

0.07

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

152

0.94

0.07

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

325

1.04

0.06

2.8

3.0

1.28

1.27

mg/l

0.01

221

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

147

1.06

0.05

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

136

895

0.98

0.05

2.0

1.9

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

109

1.07

0.05

1.0

0.10

0.32

u/ml

0.75

(3034092) Cytoplasmic Ig cells/100 cells in Blood

359

0.97

0.04

7.9

7.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

189

0.96

0.04

1.1

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1345

8729

1.00

0.03

1.3

197.50

220.79

miu/ml

1.51

544

3949

(3022475) Manganese [Moles/volume] in Blood

194

1.03

0.03

1.2

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

108

708

0.99

0.03

1.2

215.00

597.71

titre

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

304

1.02

0.02

1.5

2.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

169

1.03

0.02

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1451

9376

1.00

0.01

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

412

2658

1.00

0.01

1.6

2.0

6.87

8.62

umol/l

1.39

288

1940

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

361

0.99

0.01

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

198

1.01

0.00

1.3

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.00

0.00

1.3

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

540

0.99

0.00

4.7

5.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

250

1.01

0.00

1.0

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

172

1.02

0.00

1.1

1.3

248.00

1119.47

u/l

0.95

151

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

375

1.00

0.00

3.4

3.0

40.31

41.76

umol/l

0.22

321

(3044316) Mercury [Moles/volume] in Urine

0.87

0.00

1.4

2.5

4.00

11.72

nmol/l

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.95

-0.00

1.2

1.1

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.95

-0.00

1.0

169.20

166.38

g/l

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.91

-0.00

2.4

2.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.86

-0.00

1.0

2.92

9.95

u/ml

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.7

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.89

-0.00

6.4

3.6

—

(3022670) pH of Venous cord blood

0.92

-0.00

1.0

1.1

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_SLEEPAPNO and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_SLEEPAPNO	1.299 [1.17, 1.45]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.467

During the follow-up period (1.1.1998 — 31.12.2019), 5162 out of 72202 females with G6_SLEEPAPNO died.

Males

Parameter	HR [95% CI]	p-value
G6_SLEEPAPNO	1.153 [1.05, 1.27]	0.003
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 15538 out of 147116 males with G6_SLEEPAPNO died.

Mortality risk

Mortality risk for people of age

years, who have G6_SLEEPAPNO.

N-year risk	Females	Males
1	0.102%	0.183%
5	0.653%	1.187%
10	1.977%	2.987%
15	3.707%	5.684%
20	6.428%	9.619%

Relationships between endpoints

↥

Index endpoint: G6_SLEEPAPNO – Sleep apnoea

GWS hits: 47

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sleep apnoea

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints